23.10.2014 Views

Although 2009 is certainly a year to forget - Unquote

Although 2009 is certainly a year to forget - Unquote

Although 2009 is certainly a year to forget - Unquote

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

unquote<br />

France<br />

LA RÉFÉRENCE PAR EXCELLENCE DU PRIVATE EQUITY EN FRANCE<br />

Issue 114 AUGUST/SEPTEMBER 2010<br />

Early-stage and expansion deals: less <strong>is</strong> more<br />

FOLLOWING SUBDUED DEAL activity in May, France saw a strong<br />

increase in early-stage and expansion transactions in June. In the last<br />

few weeks, unquote” has covered 16 such deals, doubling May’s <strong>to</strong>tal.<br />

However, the French market <strong>is</strong> still lagging behind last <strong>year</strong>’s level of<br />

activity in terms of volume.<br />

<strong>Although</strong> <strong>2009</strong> <strong>is</strong> <strong>certainly</strong> a <strong>year</strong> <strong>to</strong><br />

<strong>forget</strong> for most private equity professionals,<br />

Volume<br />

France saw more early-stage and expansion<br />

Value<br />

20<br />

investments in the first half of <strong>2009</strong> than<br />

over the same period in 2010: 81 such 15<br />

transactions were recorded by unquote” in<br />

<strong>2009</strong>, against 63 th<strong>is</strong> <strong>year</strong>.<br />

10<br />

Despite th<strong>is</strong> relative slowdown, the<br />

5<br />

overall value of deals has seen a slight but<br />

noticeable increase in 2010. Early-stage<br />

0<br />

January February March<br />

and expansion transactions in the first six<br />

months of <strong>2009</strong> amounted <strong>to</strong> 477m,<br />

Volume<br />

SINCE THE BEGINNING of the <strong>year</strong>,<br />

France has been the most dynamic market for<br />

investments in the internet sec<strong>to</strong>r, along with<br />

Germany. Activity picked up again th<strong>is</strong> month,<br />

echoing the surge witnessed last March.<br />

Crédit Agricole Private Equity and A Plus<br />

Finance provided 4m for e-commerce<br />

solutions provider Oxat<strong>is</strong>, which helps<br />

French SMEs <strong>to</strong> set up their own merchant<br />

sites (see page 20). Meanwhile, BNP Paribas<br />

Private Equity invested a further 1.8m in<br />

internet communications special<strong>is</strong>t Acropol<strong>is</strong><br />

while the aggregated value th<strong>is</strong> <strong>year</strong> stands at 506m. The average deal<br />

value in France therefore has increased from 5.89m in the first half of<br />

<strong>2009</strong> <strong>to</strong> 8.04m in 2010, indicating larger investment rounds. Th<strong>is</strong> has<br />

largely been driven by the renewed interest in the life sciences sec<strong>to</strong>r,<br />

which usually requires bigger financing<br />

rounds. The number of investments<br />

in pharmaceutical and biotechnology<br />

companies has gone up from four in <strong>2009</strong><br />

150<br />

120<br />

90<br />

<strong>to</strong> six in 2010. But more significantly, their<br />

value has increased almost five-fold, from<br />

12m <strong>to</strong> 57m.<br />

The first weeks of July seem <strong>to</strong> confirm<br />

60<br />

30<br />

the sec<strong>to</strong>r’s vitality: France witnessed its<br />

largest series-A round of financing in almost<br />

five <strong>year</strong>s, with the 16m investment in<br />

0<br />

April May June<br />

Poxel – another biotechnology company<br />

Source: unquote”/Private Equity Insight (see page 17).<br />

Early-stage and expansion deals in France - H1 2010<br />

French internet sec<strong>to</strong>r continues <strong>to</strong> flour<strong>is</strong>h<br />

Value (m)<br />

Telecom (see page 21).<br />

On the exit side, private equity inves<strong>to</strong>rs<br />

have sold their stakes in France’s biggest e-<br />

commerce success-s<strong>to</strong>ry, with the 200m sale<br />

of PriceMin<strong>is</strong>ter <strong>to</strong> Japanese group Rakuten<br />

(see page 28).<br />

Have you v<strong>is</strong>ited the new France homepage yet?<br />

www.unquote.com/france<br />

Can’t log in? Don’t know your username or password?<br />

Contact Nicola Tillin on +44 207 484 9884 or nicola.tillin@inc<strong>is</strong>ivemedia.com<br />

Quick view<br />

Funds 04<br />

News in brief 05<br />

People 06<br />

Corporate M&A 08<br />

Tertiary buyouts 09<br />

Life sciences 10<br />

ILPA 11<br />

Watch 12<br />

European round-up 14<br />

Deal sec<strong>to</strong>r index 16<br />

Exits 28<br />

Funds ra<strong>is</strong>ing 32<br />

Funds investing 34<br />

IPO tracker 40<br />

Diary dates 42<br />

ENTIRE CONTENTS COPYRIGHT 2010 INCISIVE MEDIA INVESTMENTS LTD UNQUOTE AUGUST/SEPTEMBER 10 01<br />

www.unquote.com/france


In <br />

uncertain times, there are still some<br />

investments <br />

that will pay dividends. IE<br />

Consulting <br />

can help you understand<br />

how <br />

current and future developments<br />

will <br />

impact your reputation and your<br />

ability <br />

<strong>to</strong> do business. And we can<br />

tell <br />

you how your competition will be<br />

affected, <br />

<strong>to</strong>o. We can also help you ra<strong>is</strong>e<br />

capital, <br />

source and execute deals and<br />

safeguard <br />

and create value.<br />

<br />

<br />

<br />

<br />

<br />

<br />

supporting <br />

private equity


unquote<br />

contents<br />

04<br />

08<br />

News<br />

Funds 04<br />

News in brief 05<br />

People 06<br />

Analys<strong>is</strong><br />

Corporate M&A 08<br />

Tertiary buyouts 09<br />

Life sciences 10<br />

ILPA 11<br />

Watch 12<br />

European round-up 14<br />

Deals<br />

Deal sec<strong>to</strong>r index 16<br />

Early-stage 17<br />

Poxel 17<br />

McPhy Energy 17<br />

EyeTechCare 18<br />

Expansion 19<br />

Groupe Chr<strong>is</strong>tian Bernard 19<br />

Redman Promotion 19<br />

Oxat<strong>is</strong> 20<br />

Nuxeo 20<br />

Acropol<strong>is</strong> Telecom 21<br />

Novapost 22<br />

Devederm 22<br />

Comu<strong>to</strong> (Covoiturage.fr) 23<br />

FInteractive 24<br />

Intégral Système 24<br />

Kall<strong>is</strong>ta Energy 25<br />

Buyouts 26<br />

Thermocoax 26<br />

Hyper Embal/Valeurd<strong>is</strong> 27<br />

Groupe ACR 27<br />

Exits<br />

PriceMin<strong>is</strong>ter 28<br />

Carmat SAS 29<br />

Groupe Keria 30<br />

Trecobat 30<br />

Funds ra<strong>is</strong>ing 32<br />

Funds investing 34<br />

IPO tracker 40<br />

Diary dates 42<br />

16<br />

28<br />

We aim <strong>to</strong> validate fully all<br />

investment, divestment and fundra<strong>is</strong>ing<br />

data via direct contact with the<br />

investment professionals themselves.<br />

Th<strong>is</strong> policy, combined with the scale of<br />

our edi<strong>to</strong>rial and research operation,<br />

enables Inc<strong>is</strong>ive Financial Publ<strong>is</strong>hing<br />

journals <strong>to</strong> offer the prov<strong>is</strong>ion of broad,<br />

detailed and accurate data.<br />

Follow us on Twitter for<br />

breaking French private<br />

equity news:<br />

twitter.com/Franceunquote<br />

ISSN – 1467-0062<br />

Volume 2010/8<br />

Annual Subscription (Standard Plus):<br />

£1,500/2,250/$2,700<br />

Publ<strong>is</strong>hed by<br />

Inc<strong>is</strong>ive Financial Publ<strong>is</strong>hing ltd<br />

Haymarket House<br />

28-29 Haymarket<br />

London<br />

SW1Y 4RX<br />

UK<br />

Tel: +44 20 7484 9700<br />

Fax: +44 20 7004 7548<br />

All rights reserved. No part of th<strong>is</strong> publication<br />

may be reproduced or s<strong>to</strong>red in a database or<br />

electronic retrieval system, transmitted in any<br />

form or by any means, electronic, mechanical,<br />

pho<strong>to</strong>copied, recorded or otherw<strong>is</strong>e, without<br />

prior written perm<strong>is</strong>sion from the publ<strong>is</strong>hers. No<br />

statement in th<strong>is</strong> journal <strong>is</strong> <strong>to</strong> be construed as a<br />

recommendation <strong>to</strong> buy or sell securities.<br />

Acting Edi<strong>to</strong>r-in-Chief &<br />

Head of Research<br />

Emanuel Eftimiu<br />

emanuel.eftimiu@inc<strong>is</strong>ivemedia.com<br />

Edi<strong>to</strong>r-in-Chief<br />

Kimberly Romaine<br />

kimberly.romaine@inc<strong>is</strong>ivemedia.com<br />

Reporters<br />

Gregoire Gille – gregoire.gille@inc<strong>is</strong>ivemedia.com<br />

Vik<strong>to</strong>r Lundvall – vik<strong>to</strong>r.lundvall@inc<strong>is</strong>ivemedia.com<br />

Gail Mwamba – gail.mwamba@inc<strong>is</strong>ivemedia.com<br />

Online Edi<strong>to</strong>r<br />

John Bakie<br />

john.bakie@inc<strong>is</strong>ivemedia.com<br />

Publ<strong>is</strong>hing Direc<strong>to</strong>r<br />

Catherine Lew<strong>is</strong><br />

catherine.lew<strong>is</strong>@inc<strong>is</strong>ivemedia.com<br />

Advert<strong>is</strong>ing & Sponsorship Manager<br />

Stephen O’Sullivan<br />

stephen.osullivan@inc<strong>is</strong>ivemedia.com<br />

Production Edi<strong>to</strong>r<br />

Tim Kimber<br />

tim.kimber@inc<strong>is</strong>ivemedia.com<br />

Sub-edi<strong>to</strong>r<br />

Eleanor Stanley<br />

eleanor.stanley@inc<strong>is</strong>ivemedia.com<br />

Marketing<br />

Helen Longhurst<br />

helen.longhurst@inc<strong>is</strong>ivemedia.com<br />

Subscription Sales<br />

Nicola Tillin<br />

nicola.tillin@inc<strong>is</strong>ivemedia.com<br />

ENTIRE CONTENTS COPYRIGHT 2010 INCISIVE MEDIA INVESTMENTS LTD UNQUOTE AUGUST/SEPTEMBER 10 03<br />

www.unquote.com/france


funds<br />

Name<br />

Gilde Buyout Fund IV<br />

Closed on<br />

800m (June 2010)<br />

Focus<br />

Buyouts, mid-market, Europe<br />

Contact<br />

Koos Teule<br />

Gilde Buy Out Partners BV<br />

New<strong>to</strong>nlaan 91<br />

PO Box 85067<br />

3508 AB Utrecht<br />

Netherlands<br />

Tel : +31 30 219 2508<br />

Adv<strong>is</strong>ers<br />

MV<strong>is</strong>ion (Placement agent); SJ<br />

Berwin (Legal)<br />

unquote<br />

Gilde’s latest fund reaches 800m hard-cap<br />

Fund<br />

Gilde Buyout Partners has closed its Gilde Buyout Fund IV on 800m. Launched in March <strong>2009</strong>,<br />

the vehicle has a 10-<strong>year</strong> lifespan, with the potential <strong>to</strong> extend by two one-<strong>year</strong> periods. Based in the<br />

Netherlands, the fund was oversubscribed and reached its hard-cap following strong inves<strong>to</strong>r interest.<br />

Management fees have been set at 1.65%, while the hurdle and carry follow the industry standard of<br />

8% and 20% respectively. Carried interest will be paid on the fund as a whole. MV<strong>is</strong>ion acted as global<br />

placing agent and SJ Berwin was mandated as legal adv<strong>is</strong>er. Gilde’s previous buyout fund, Gilde Buyout<br />

Fund III, reached its 600m target in September 2006. To date, it has completed nine investments.<br />

Inves<strong>to</strong>rs<br />

The fund has attracted 45 contribu<strong>to</strong>rs, with several previous Gilde inves<strong>to</strong>rs returning. 50% of<br />

commitments came from Europe, 35% from the US and 15% from the Asia Pacific. Pension plans and<br />

sovereign wealth funds account for the majority of the inves<strong>to</strong>r base.<br />

Investments<br />

Gilde aims <strong>to</strong> make equity investments of 25-200m in mid-market companies across a wide range of<br />

industries, with a core focus on the Benelux, German-speaking and French economies. The fund expects<br />

<strong>to</strong> perform around 15 investments over its lifetime, several of which are said <strong>to</strong> be already in the pipeline.<br />

People<br />

The fund <strong>is</strong> managed by the Gilde buyout team, led by Boudewijn Molenaar.<br />

Name<br />

Argos Expansion<br />

Closed on<br />

45m (July 2010)<br />

Target<br />

120m<br />

Focus<br />

Expansion, SMEs, France<br />

Contact<br />

Constance Jay<br />

Argos Soditic<br />

14, rue de Bassano<br />

75783 Par<strong>is</strong> Cedex 16<br />

France<br />

Tel: +33 1 53 67 20 50<br />

Adv<strong>is</strong>ers<br />

Proskauer Rose (Legal)<br />

Latest Argos fund holds 45m first close<br />

Fund<br />

Argos Soditic has closed its Argos Expansion fund on 45m. The vehicle will make its first investments while<br />

continuing <strong>to</strong> ra<strong>is</strong>e funds from LPs, with a final target of 120m. The fund has a 10-<strong>year</strong> lifespan with a five<strong>year</strong><br />

investment period. Officially launched in January 2008, it started receiving commitments in <strong>2009</strong>.<br />

Based in France, Argos Expansion <strong>is</strong> an FCPR benefiting from simplified author<strong>is</strong>ation procedures.<br />

Management fees have been set at 2%, hurdle at 7% and carry at 20%. While no placing agent was<br />

mandated, Proskauer Rose acts as legal adv<strong>is</strong>er <strong>to</strong> the fund.<br />

Inves<strong>to</strong>rs<br />

Argos Expansion has received commitments from 14 inves<strong>to</strong>rs so far. The EIF and CDC Entrepr<strong>is</strong>es,<br />

acting on behalf of the French Strategic Investment Fund (FSI), have contributed along with the three<br />

fund managers. The vehicle <strong>is</strong> looking <strong>to</strong> attract commitments from France and the rest of Europe.<br />

Investments<br />

The fund will provide development and acqu<strong>is</strong>ition financing for small and medium-sized French<br />

enterpr<strong>is</strong>es (SMEs) already held or being acquired by their management teams. It will typically invest<br />

between 2-12m in junior capital (sponsorless mezzanine) and minority equity. The fund should<br />

perform between 10-15 investments in businesses with enterpr<strong>is</strong>e values ranging from 10-100m.<br />

People<br />

An independent management team cons<strong>is</strong>ting of three partners – Olivier Bossan, Lou<strong>is</strong> de Lestanville<br />

and Jean de Sampigny – will manage the fund’s operations and investments.<br />

04 UNQUOTE AUGUST/SEPTEMBER 10 ENTIRE CONTENTS COPYRIGHT 2010 INCISIVE MEDIA INVESTMENTS LTD<br />

www.unquote.com/france


unquote<br />

Carlyle set <strong>to</strong> exit O<strong>to</strong>r<br />

CARLYLE HAS entered in<strong>to</strong> exclusive d<strong>is</strong>cussions with<br />

packaging and office supplies wholesaler DS Smith, regarding<br />

the acqu<strong>is</strong>ition of Carlyle’s stake in l<strong>is</strong>ted company O<strong>to</strong>r.<br />

The transaction would involve the sale of 94.75% of O<strong>to</strong>r’s share<br />

capital, which Carlyle acquired in 2005. In addition, shares<br />

retained by O<strong>to</strong>r’s chairman would also be sold <strong>to</strong> DS Smith,<br />

which would then control more than 95% of the company.<br />

DS Smith has offered 8.97 per O<strong>to</strong>r share, which would value<br />

the company at 247m, including a 47m debt. Following<br />

completion of the transaction by the end of 2010, DS Smith<br />

intends <strong>to</strong> launch an offer for the remaining l<strong>is</strong>ted shares. O<strong>to</strong>r <strong>is</strong> a<br />

French corrugated cardboard packaging manufacturer, operating<br />

six box plants, three specialty sheet plants, two paper mills and<br />

one packaging machine unit. Floated on NYSE Alternext Par<strong>is</strong> in<br />

1998, it posted revenues of 315m in <strong>2009</strong>.<br />

news in brief<br />

Avenir et al. back Société<br />

Hôtelière Côte Rôtie<br />

AVENIR ENTREPRISES, Sofival, BNP Paribas<br />

Développement, Garibaldi Participations and R<strong>is</strong>que &<br />

Sérénité have funded the buyout of eight hotels on behalf of<br />

Société Hôtelière Côte Rôtie (SHCR).<br />

The eight hotels, located in the Rhône-Alpes region of France,<br />

were acquired from Groupe Accor for an und<strong>is</strong>closed amount.<br />

Sofival, a local real estate developer, contributed 39% of the<br />

funds. The remainder was provided by private equity houses<br />

Avenir Entrepr<strong>is</strong>es (21%), BNP Paribas Développement (17%),<br />

Garibaldi Participations (7%) and R<strong>is</strong>que & Sérénité (5%).<br />

SHCR was created <strong>to</strong> operate hotels and aims <strong>to</strong> take<br />

advantage of the region’s <strong>to</strong>ur<strong>is</strong>t potential, especially for<br />

skiing holidays.<br />

AIFM vote put back <strong>to</strong> autumn<br />

A CRUCIAL VOTE on the AIFM<br />

Directive has been delayed until<br />

September.<br />

Issues regarding third country rules,<br />

which would limit the capabilities of<br />

non-EU domiciled hedge, private<br />

equity and venture capital funds, led<br />

<strong>to</strong> the collapse of talks between the<br />

European parliament and country<br />

representatives.<br />

The European comm<strong>is</strong>sion had set<br />

an ambitious target of agreeing the<br />

regulations by the end of th<strong>is</strong> month.<br />

However, the Span<strong>is</strong>h EU presidency<br />

says it will not be possible <strong>to</strong> reach an<br />

agreement in June, and the vote has<br />

now been delayed until the second<br />

parliamentary session in September<br />

th<strong>is</strong> <strong>year</strong>.<br />

A delay in holding the vote gives<br />

lobby<strong>is</strong>ts crucial extra time <strong>to</strong> push<br />

for changes in the draft leg<strong>is</strong>lation,<br />

which could negatively impact private<br />

equity and venture capital investment<br />

in Europe.<br />

Seventure leads Nutrionix investment<br />

PREVIOUS INVESTORS Seventure Partners have worked with seven business<br />

angels <strong>to</strong> provided additional funding for French-based Nutrionix, a company that<br />

special<strong>is</strong>es in the reduction of sodium in food.<br />

The first round of funding from Seventure of 900,000 completed in spring<br />

<strong>2009</strong> enabled Nutrionix <strong>to</strong> launch its first commercial product, K-Salt, and<br />

accelerate product development. Th<strong>is</strong> second round of funding was arranged<br />

<strong>to</strong> take advantage of increasingly receptive market conditions and the need <strong>to</strong><br />

accelerate development.<br />

Lloyds sells UK<br />

portfolio <strong>to</strong><br />

Coller Capital<br />

LLOYDS BANKING GROUP has<br />

become the latest bank <strong>to</strong> cut its private<br />

equity exposure, selling its £480m<br />

portfolio of UK private equity stakes <strong>to</strong><br />

a newly created joint venture, Cavend<strong>is</strong>h<br />

Square Partners.<br />

Lloyds will jointly own the venture with<br />

Coller Capital, which has agreed <strong>to</strong> pay<br />

£332m for 70% of the venture, while the<br />

bank maintains a 30% stake.<br />

The deal will see a transfer of 40 UK<br />

trading companies <strong>to</strong> the new vehicle,<br />

currently managed by Bank of Scotland<br />

Integrated Finance (BOSIF). Coller<br />

won the deal through an auction<br />

process, with the agreement subject <strong>to</strong><br />

regula<strong>to</strong>ry approval.<br />

Lloyds expects <strong>to</strong> complete the transfer<br />

of the assets and ex<strong>is</strong>ting BOSIF<br />

management team <strong>to</strong> the new vehicle by<br />

the third quarter of 2010.<br />

ENTIRE CONTENTS COPYRIGHT 2010 INCISIVE MEDIA INVESTMENTS LTD UNQUOTE AUGUST/SEPTEMBER 10 05<br />

www.unquote.com/france


news in brief<br />

LBO France plans<br />

Medi-Partenaires exit<br />

LBO FRANCE <strong>is</strong> working on plans <strong>to</strong> exit its stake in French<br />

healthcare provider Medi-Partenaires SA, according <strong>to</strong> media<br />

reports. Rothschild has reportedly been hired <strong>to</strong> handle the<br />

sale, which <strong>is</strong> estimated <strong>to</strong> be valued at about 1bn.<br />

LBO France led the 600m secondary buyout of the company<br />

in 2007, investing alongside Barclays Private Equity, Crédit<br />

Agricole and Intermediate Capital.<br />

unquote<br />

AlpInvest sale rumoured<br />

THE OWNERS OF private equity heavyweight AlpInvest could<br />

be looking for a sale, according <strong>to</strong> reports. AlpInvest <strong>is</strong> owned<br />

by Dutch pension funds ABP and PGGM. ABP, AlpInvest and<br />

Crédit Su<strong>is</strong>se, which <strong>is</strong> rumoured <strong>to</strong> have been mandated for<br />

the sale, have all declined <strong>to</strong> comment.<br />

Founded in 1999, AlpInvest <strong>is</strong> one of the largest European<br />

private equity firms. With more than 40bn under management,<br />

it special<strong>is</strong>es in fund investments, secondary investments, coinvestments<br />

and mezzanine transactions.<br />

AXA Private Equity buys Phönix/Strack Group<br />

AXA PRIVATE EQUITY has acquired<br />

a majority stake in Phönix/Strack<br />

Group, a special valves supplier <strong>to</strong> the<br />

chemicals industry.<br />

No financial details for the transaction have<br />

been d<strong>is</strong>closed, but the inves<strong>to</strong>r <strong>is</strong> looking<br />

<strong>to</strong> grow the company internationally<br />

through add-on acqu<strong>is</strong>itions, as well as by<br />

exploiting ex<strong>is</strong>ting market opportunities.<br />

Founded in 1910, Phönix/Strack<br />

manufactures special valves for<br />

international blue-chip companies in<br />

the fields of energy, petrochemicals and<br />

chemicals. The group generated revenues<br />

of approximately 40m in <strong>2009</strong> and<br />

employs a workforce of 250 at its plants<br />

in Volkmarsen and Magdeburg, as well<br />

as through its sales entities in France and<br />

the US.<br />

people moves<br />

Edmond de<br />

Rothschild CP<br />

strengthens team<br />

Edmond de Rothschild Capital Partners<br />

has recruited a new investment direc<strong>to</strong>r<br />

and analyst. It has also promoted one of<br />

its analysts <strong>to</strong> asset manager.<br />

Aymeric Marraud des Grottes has been<br />

appointed as investment direc<strong>to</strong>r. He<br />

previously worked as an analyst and later<br />

associate for JP Morgan, which he joined<br />

in 2001.<br />

Marie Londero <strong>is</strong> joining the firm as an<br />

analyst, having recently graduated from<br />

the ESCP-EAP school.<br />

BNP Paribas Private Equity<br />

appoints Rivet-Fusil as FoF head<br />

BNP Paribas Private Equity has appointed Jean-Marc Rivet-Fusil <strong>to</strong> head its fundsof-funds<br />

team. He has been charged with defining and implementing the firm’s<br />

fund-of-funds strategy, which includes defining and supporting the d<strong>is</strong>tribution<br />

of tailored offerings.<br />

Rivet-Fusil will form part of the two-person investment committee, working alongside<br />

Stéphanie Egoian, who has been promoted <strong>to</strong> chief investment officer. Egoian will be<br />

in charge of coordinating the fund’s investment strategy <strong>to</strong> define its funds selection<br />

and investment processes.<br />

Rivet-Fusil joined BNP Paribas in 2007 as chief investment officer, coming<br />

from Amundi. He has also held previous roles at Access Capital Partners, Banexi<br />

Ventures Partners and Banexi Participations, covering funds selection, venture<br />

capital, buyouts and mezzanine financing. Egoian joined as investment direc<strong>to</strong>r<br />

in 1999 and has also worked as chief financial officer of the company’s Europe<br />

Telecom & Media Fund.<br />

06 UNQUOTE AUGUST/SEPTEMBER 10 ENTIRE CONTENTS COPYRIGHT 2010 INCISIVE MEDIA INVESTMENTS LTD<br />

www.unquote.com/france


EUROPEAN<br />

FUNDRAISING<br />

REVIEW 2010<br />

LOOKING TO RAISE FUNDS IN<br />

EUROPE IN 2010 AND BEYOND?<br />

The ninth edition of the European Fundra<strong>is</strong>ing Review <strong>is</strong> out now.<br />

Th<strong>is</strong> essential guide provides you with an in-depth analys<strong>is</strong> of<br />

private equity and venture capital fundra<strong>is</strong>ing activity for each major<br />

European region.<br />

Order your copy now by calling+44 (0)20 7968 4506<br />

and quoting ref: FPA<br />

In association with:<br />

unquote.com


corporate M&A<br />

unquote<br />

Corporates trump private equity<br />

in European M&A<br />

Private equity continues <strong>to</strong> lag behind corporate buyers in size of merger and<br />

acqu<strong>is</strong>ition (M&A) deals executed in Europe, as cash-rich corporate players flex<br />

their muscles <strong>to</strong> offer both capital and synergies in the space.<br />

Gail Mwamba reports<br />

The first half of th<strong>is</strong> <strong>year</strong> has seen a significant pick-up in<br />

M&A activity, with deal-making in Europe estimated <strong>to</strong> have<br />

reached about $230bn in the first half of 2010. A significant<br />

number of these deals have been executed by corporates<br />

making acqu<strong>is</strong>itions, which includes the purchase of Cogn<strong>is</strong><br />

by BASF for an estimated enterpr<strong>is</strong>e value of 3.1bn.<br />

According <strong>to</strong> Edward<br />

Boyce, Nomura’s Londonbased<br />

managing direc<strong>to</strong>r of<br />

investment banking, the <strong>to</strong>p<br />

20 largest deals seen in Europe,<br />

the Middle East and Africa<br />

(EMEA) th<strong>is</strong> <strong>year</strong> have been<br />

executed by corporates.<br />

“The <strong>to</strong>p deals we have seen<br />

th<strong>is</strong> <strong>year</strong> in EMEA, in terms<br />

of size, have been corporates<br />

buying corporates,” says Boyce.<br />

“They are situations where a trade buyer <strong>is</strong> a better solution,<br />

and a private equity inves<strong>to</strong>r cannot compete because it <strong>is</strong><br />

not able <strong>to</strong> provide the same synergies.”<br />

According <strong>to</strong> Boyce, corporate players are able <strong>to</strong> sometimes<br />

win over vendors because they generally offer a longer<br />

holding period, while private equity inves<strong>to</strong>rs tend <strong>to</strong> seek<br />

<strong>to</strong> exit within three <strong>to</strong> five <strong>year</strong>s.<br />

Corporates are also able <strong>to</strong> reign in situations where the target<br />

company will require constant streams of cash <strong>to</strong> survive,<br />

which may be a d<strong>is</strong>advantage for private equity players who<br />

are generally geared <strong>to</strong> finance acqu<strong>is</strong>itions. In recent times,<br />

corporates have increasingly been able <strong>to</strong> provide th<strong>is</strong> kind<br />

of support, as many are sitting on large pots of money, some<br />

of which has been gained through retained earnings.<br />

“Securing funding <strong>is</strong> not<br />

an <strong>is</strong>sue for us, as we have<br />

cashflows that have been<br />

generated organically,”<br />

says Swag Mukerji, chief<br />

financial officer at Londonbased<br />

washing machine<br />

producer SafetyKleen.<br />

“Fortunately, we have been<br />

resilient <strong>to</strong> the recession.”<br />

However, the availability<br />

for corporates of sustained<br />

cashflow and the potential for synergies with their targets has<br />

not been enough <strong>to</strong> purchase significant assets from private<br />

equity players.<br />

According <strong>to</strong> unquote” data, although exiting via trade sales<br />

constituted about 44% of deal volume in the first half of 2010,<br />

th<strong>is</strong> only amounted <strong>to</strong> 17% of <strong>to</strong>tal value. Th<strong>is</strong> <strong>is</strong> compared<br />

<strong>to</strong> secondary buyouts, where 28% of volume equated <strong>to</strong> 44%<br />

in deal value. It remains <strong>to</strong> be seen if corporates will extend<br />

their reign <strong>to</strong> th<strong>is</strong> space as well. <br />

08 UNQUOTE AUGUST/SEPTEMBER 10 ENTIRE CONTENTS COPYRIGHT 2010 INCISIVE MEDIA INVESTMENTS LTD<br />

www.unquote.com/france


unquote<br />

tertiary buyouts<br />

Tertiary buyouts:<br />

passing it on<br />

As deal-making fever returns <strong>to</strong> the market, tertiary sales appear <strong>to</strong> be<br />

back in vogue for a number of private equity inves<strong>to</strong>rs looking <strong>to</strong> put<br />

their secondary assets on the block. Gail Mwamba reports<br />

French pharmaceutical firm Cerba European Lab was recently<br />

sold by IK Investment Partners <strong>to</strong> PAI partners in an estimated<br />

500m tertiary buyout. PAI backed the 2006 secondary buyout<br />

from As<strong>to</strong>rg Partners. However, the company’s private equity<br />

investment h<strong>is</strong><strong>to</strong>ry stretches back even further, having been backed<br />

by Initiative & Finance and Natex<strong>is</strong> in a previous funding round.<br />

Barclays Private Equity also chose <strong>to</strong> go with a private equity<br />

player in its sale of UK luggage brand Antler in May, <strong>to</strong> Lloyds<br />

Development Capital – the third time the firm had been backed<br />

by a private equity inves<strong>to</strong>r. BPE bought the company from<br />

Royal Bank Equity Finance in 2004, with the vendor having<br />

backed its first buyout in 1999.<br />

Some tertiary deals have been spurred by inves<strong>to</strong>rs looking for<br />

more experienced buyers able <strong>to</strong> offer speed of execution as well<br />

as an attractive deal price. Th<strong>is</strong> was the case for Change Capital<br />

Partners, which th<strong>is</strong> month sold UK fashion retailer Republic in<br />

a tertiary deal <strong>to</strong> TPG Capital for an estimated £300m. Change<br />

Capital backed the company in a 2005 SBO from 3i.<br />

“There was a lot of private equity and trade interest in the<br />

business, and we made the dec<strong>is</strong>ion <strong>to</strong> pursue the option of<br />

a financial buyer based on both price and timing,” says Steve<br />

Petrow, managing direc<strong>to</strong>r at Change Capital Partner in<br />

London. “Trade players had a lot of interest, but the time frame<br />

that we were working within was quite difficult.”<br />

However, for Herkules, which recently sold Nordic healthcare<br />

equipment manufacturer Handicare <strong>to</strong> Nordic Capital, financial<br />

backers were specifically sought as Handicare was in need of<br />

fresh capital. Herkules, which had bought the company from<br />

AAC Capital Partners in 2005, ran out of capital in its first fund<br />

and was not able <strong>to</strong> finance further growth.<br />

“We invited only financial parties, and we had strong interest<br />

from Nordic and European funds, as well as US funds with<br />

offices in Europe,” says Patrik Egeland, partner at Herkules in<br />

Oslo. “We felt the company would benefit from having more<br />

capital <strong>to</strong> grow.”<br />

According <strong>to</strong> Petrow, the industry <strong>is</strong> expecting <strong>to</strong> see more<br />

tertiary deals in the future. Th<strong>is</strong> may well be the case, with recent<br />

reports of private equity buyers reportedly having joined the race<br />

<strong>to</strong> buy Bain Capital’s Italian software company, TeamSystem<br />

SpA, for an estimated 600m. Bain bought the company in a<br />

secondary buyout from Palamon Capital Partners in 2004.<br />

The spurt in tertiary activity may reflect difficult conditions<br />

in other exit markets, as the world economy remains weak.<br />

However, with some sellers specifically targeting other private<br />

equity buyers, believing they can bring something more <strong>to</strong> the<br />

business, it could indicate inves<strong>to</strong>rs are adopting a longer-term<br />

view, hoping their portfolio companies will continue <strong>to</strong> thrive<br />

long after inves<strong>to</strong>r and company part ways. <br />

ENTIRE CONTENTS COPYRIGHT 2010 INCISIVE MEDIA INVESTMENTS LTD UNQUOTE AUGUST/SEPTEMBER 10 09<br />

www.unquote.com/france


life sciences<br />

unquote<br />

Life sciences:<br />

testing times ahead?<br />

Pharmaceuticals and biotechnology have fared marginally better than other sec<strong>to</strong>rs<br />

during the global recession, but the last two <strong>year</strong>s have still been lacklustre for<br />

private equity investments in life sciences. However, with a healthy number of deals<br />

already th<strong>is</strong> <strong>year</strong>, what <strong>is</strong> on the cards for the rest of 2010? Greg Gille reports<br />

As in many sec<strong>to</strong>rs, the <strong>to</strong>p end of the life sciences market<br />

struggled the most in both 2008 and <strong>2009</strong>. Buyouts more than<br />

halved; unquote” only recorded four each <strong>year</strong>, down from a 10<br />

per <strong>year</strong> average between 2005 and 2007. Expansion deals were<br />

also scarce, with 16 in 2008 and 18 in <strong>2009</strong>, compared <strong>to</strong> an<br />

average 35 per <strong>year</strong> recorded between 2005 and 2007.<br />

However, early-stage investments remained in line with<br />

pre-2007 levels. <strong>2009</strong> saw 54 venture capital investments, a<br />

marginal improvement on the<br />

46 per <strong>year</strong> average recorded<br />

between 2004 and 2006.<br />

Venture capital<strong>is</strong>ts remained<br />

active throughout the cr<strong>is</strong><strong>is</strong>,<br />

betting strategic investments<br />

in innovative businesses would<br />

prove fruitful in the coming<br />

<strong>year</strong>s. Michiel de Haan,<br />

partner at venture firm Aescap,<br />

explains: “We are interested<br />

in companies that are very<br />

ambitious and we therefore aim<br />

for the long term. If you want<br />

<strong>to</strong> be a successful venture firm in life sciences, you cannot look<br />

for exits on the short term.”<br />

So far th<strong>is</strong> <strong>year</strong>, there have been five buyouts in the sec<strong>to</strong>r,<br />

already <strong>to</strong>pping both 2008 and <strong>2009</strong>. The <strong>year</strong> started with<br />

a bang from Charterhouse Capital, which bought Deb Group<br />

from Barclays for a generous £325m. Other notable deals<br />

include AAC Capital’s £100m acqu<strong>is</strong>ition of Martindale<br />

Pharmaceuticals, as well as the £400m Cerba Lab buyout by<br />

PAI partners.<br />

As far as venture investments are concerned, the 27 earlystage<br />

and 14 expansion deals recorded in the first half of 2010<br />

point <strong>to</strong> a return <strong>to</strong> pre-cr<strong>is</strong><strong>is</strong> levels of activity, in both volume<br />

and value. De Haan highlights the strengths of Europe for the<br />

near future: “Life sciences has a very favourable outlook, with<br />

an ageing population and a growing need for better medicine<br />

and healthcare; emerging countries also offer opportunities<br />

for European life sciences firms. Technology has always been<br />

better in Europe than in the US; what has been lacking for the<br />

last 20 <strong>year</strong>s and now reversed<br />

<strong>is</strong> the human capital.”<br />

That <strong>is</strong>, of course, if inves<strong>to</strong>rs<br />

stay on track, for a looming<br />

hurdle might test their resolve<br />

<strong>to</strong> support innovation through<br />

the economic slowdown. The<br />

AIFM Directive <strong>is</strong> <strong>certainly</strong> a<br />

cause for concern for venture<br />

firms; portfolio d<strong>is</strong>closure in<br />

particular <strong>is</strong> seen as a major<br />

competitive d<strong>is</strong>advantage for<br />

innovative companies, left open<br />

<strong>to</strong> the prying eyes of competi<strong>to</strong>rs.<br />

The EVCA <strong>is</strong> vocally opposing the directive and warns that<br />

many firms could s<strong>to</strong>p investing al<strong>to</strong>gether. “Small startups<br />

are hit the hardest by regulation, which <strong>is</strong> aimed at big<br />

banks and large private equity houses. It <strong>is</strong> alarming how<br />

governments urge us <strong>to</strong> promote innovation, but make it very<br />

difficult for investment companies,” de Haan adds. However,<br />

he leaves the door open <strong>to</strong> optim<strong>is</strong>m: “It hurts, but obviously<br />

we have <strong>to</strong> get over it.” <br />

10 UNQUOTE AUGUST/SEPTEMBER 10 ENTIRE CONTENTS COPYRIGHT 2010 INCISIVE MEDIA INVESTMENTS LTD<br />

www.unquote.com/france


unquote<br />

ILPA<br />

Broad-brush solution<br />

<strong>to</strong> a complex <strong>is</strong>sue?<br />

In a buyer’s market it <strong>is</strong> hardly surpr<strong>is</strong>ing that there has been a real focus on realigning<br />

various terms & conditions of private equity funds <strong>to</strong> favour LP inves<strong>to</strong>rs.<br />

But are attempts <strong>to</strong> drive and perhaps formal<strong>is</strong>e th<strong>is</strong> process wide of the mark?<br />

Julian Longhurst investigates<br />

It’s a sign of the times: the inves<strong>to</strong>r relations partner of a well<br />

respected European mid-cap inves<strong>to</strong>r <strong>is</strong> nervous of h<strong>is</strong> group’s<br />

upcoming fundra<strong>is</strong>ing programme. Despite having multiple<br />

previous funds under its belt and an innate confidence in the firm’s<br />

tried and tested investment strategy, the current conditions make<br />

it hard <strong>to</strong> predict how the fundra<strong>is</strong>ing process will pan out.<br />

Of course, while there may have been a short window of<br />

fundra<strong>is</strong>ing activity in the first four or five months of the <strong>year</strong>,<br />

macroeconomic demons have<br />

once again made the situation<br />

worse for any GPs doing the<br />

fundra<strong>is</strong>ing rounds. But there are<br />

other <strong>is</strong>sues making the process<br />

more onerous: the significantly<br />

more thorough LP due diligence<br />

process <strong>is</strong> one thing, along with<br />

a strong push from the buy-side<br />

<strong>to</strong> secure more LP-friendly terms<br />

and conditions.<br />

In th<strong>is</strong> regard, LPs have had some<br />

help from the Institutional Limited<br />

Partner Association (ILPA), a US organ<strong>is</strong>ation with some 220<br />

members in 10 countries. ILPA has built a set of principles aimed<br />

at serving as “a bas<strong>is</strong> for continued d<strong>is</strong>cussion between the general<br />

partner and limited partner”. The principles have <strong>certainly</strong> lent<br />

some weight <strong>to</strong> LPs’ calls for changes in areas such as management<br />

fees, transaction fees, GP fund contributions, key-man and nofault<br />

clauses, and transparency, especially in carry d<strong>is</strong>tribution.<br />

While the general shift in power has <strong>certainly</strong> precipitated some<br />

notable concessions in Ts&Cs (note Apollo and Blacks<strong>to</strong>ne as<br />

cases in point), there are those that suggest the principles are a<br />

knee jerk reaction <strong>to</strong> <strong>is</strong>sues endemic at the <strong>to</strong>p end of the scale and<br />

represent <strong>to</strong>o simpl<strong>is</strong>tic a solution for the industry as a whole.<br />

A good example of th<strong>is</strong>, according <strong>to</strong> one mid-market special<strong>is</strong>t,<br />

<strong>is</strong> the practice of GPs taking a large slice of the transaction fees<br />

they earn, rather than passing it all <strong>to</strong> the fund: “Larger funds<br />

will never get away with th<strong>is</strong> again – it <strong>is</strong> such a conflict of<br />

interests. But, the <strong>is</strong>sue <strong>is</strong> nowhere near as clear for much smaller<br />

funds, whose operational<br />

costs are d<strong>is</strong>proportionately<br />

high in compar<strong>is</strong>on <strong>to</strong> their<br />

management fee income.<br />

For them, the ability <strong>to</strong><br />

supplement income via<br />

transaction fees can be<br />

important in some cases.”<br />

It <strong>is</strong> not just GPs who think it<br />

so, and research suggests only<br />

one in eight LPs will ins<strong>is</strong>t on<br />

the full implementation of the<br />

principles, suggesting that the<br />

“one size fits all” approach really doesn’t work.<br />

Whatever the rights or wrongs of ILPA’s principles, between<br />

now and the end of 2012 virtually every private equity group<br />

that currently invests from an external fund will have gone out<br />

<strong>to</strong> market <strong>to</strong> ra<strong>is</strong>e new money, so we could be some way from<br />

knowing exactly how far the pendulum will swing <strong>to</strong>wards LPs. <br />

A more detailed look at the fundra<strong>is</strong>ing environment will be covered<br />

in the August/September <strong>is</strong>sue of Private Equity Europe.<br />

ENTIRE CONTENTS COPYRIGHT 2010 INCISIVE MEDIA INVESTMENTS LTD UNQUOTE AUGUST/SEPTEMBER 10 11<br />

www.unquote.com/france


France watch period <strong>to</strong> end June 2010<br />

unquote<br />

PERIOD TO END<br />

JUNE 2010<br />

Figures are based on all expansion/early-stage transactions in France that were confirmed as having an<br />

institutional private equity or mezzanine inves<strong>to</strong>r as a lead or syndicate partner.<br />

For further information on Inc<strong>is</strong>ive Media’s data and research please call Emanuel Eftimiu on:<br />

+44 20 7004 7464.<br />

Volume<br />

15<br />

12<br />

9<br />

6<br />

3<br />

YTD 2010 Volume 13<br />

YTD 2010 Value<br />

€89.7m<br />

0<br />

0<br />

Q2 2005 Q4 2005 Q2 2006 Q4 2006 Q2 2007 Q4 2007 Q2 2008 Q4 2008 Q2 <strong>2009</strong> Q4 <strong>2009</strong> Q2 2010<br />

Q2 2005<br />

Q4 2005<br />

Q2 2006<br />

Q4 2006<br />

Q2 2007<br />

Q4 2007<br />

Q2 2008<br />

Q4 2008<br />

Source: unquote”<br />

Number and <strong>to</strong>tal value in m of French early-stage deals per quarter.<br />

Q2 <strong>2009</strong><br />

Q4 <strong>2009</strong><br />

Early-stage<br />

Q2 2010<br />

100<br />

80<br />

60<br />

40<br />

20<br />

Value (€m)<br />

Volume<br />

40<br />

35<br />

30<br />

25<br />

20<br />

15<br />

10<br />

5<br />

YTD 2010 Volume 48<br />

YTD 2010 Value<br />

388.2m<br />

0<br />

0<br />

Q2 2005 Q4 2005 Q2 2006 Q4 2006 Q2 2007 Q4 2007 Q2 2008 Q4 2008 Q2 <strong>2009</strong> Q4 <strong>2009</strong> Q2 2010<br />

Q2 2005<br />

Q4 2005<br />

Q2 2006<br />

Q4 2006<br />

Q2 2007<br />

Q4 2007<br />

Q2 2008<br />

Q4 2008<br />

Q2 <strong>2009</strong><br />

Q4 <strong>2009</strong><br />

Expansion<br />

Q2 2010<br />

Source: unquote”<br />

Number and <strong>to</strong>tal value in m of French expansion deals per quarter.<br />

* Does not include PIPE deals like Cinven’s 1.518bn investment in Eutelsat in Q4 2004, nor any<br />

refinancings like the SigmaKalon 1.6bn deal in Q3 2005<br />

500<br />

400<br />

300<br />

200<br />

100<br />

Value (m)<br />

Figures are based on all buyouts in France with a recorded or estimated value of 10m+ that were confirmed as having an<br />

institutional private equity or mezzanine inves<strong>to</strong>r as a lead or syndicate partner.<br />

Volume<br />

YTD 2010 Volume 15<br />

YTD 2010 Value 3.1bn<br />

60<br />

15<br />

50<br />

12<br />

40<br />

9<br />

30<br />

6<br />

20<br />

10<br />

3<br />

0<br />

0<br />

Q2 2005 Q4 2005 Q2 2006 Q4 2006 Q2 2007 Q4 2007 Q2 2008 Q4 2008 Q2 <strong>2009</strong> Q4 <strong>2009</strong> Q2 2010<br />

Q2 2005<br />

Q4 2005<br />

Q2 2006<br />

Q4 2006<br />

Q2 2007<br />

Q4 2007<br />

Q2 2008<br />

Q4 2008<br />

Q2 <strong>2009</strong><br />

Q4 <strong>2009</strong><br />

Q2 2010<br />

Buyouts<br />

Value (bn)<br />

Volume<br />

European buyouts<br />

YTD 2010 Volume 121<br />

YTD 2010 Value 19bn<br />

250<br />

80<br />

70<br />

200<br />

60<br />

150<br />

50<br />

40<br />

100<br />

30<br />

20<br />

50<br />

10<br />

0<br />

0<br />

Q2 2005 Q4 2005 Q2 2006 Q4 2006 Q2 2007 Q4 2007 Q2 2008 Q4 2008 Q2 <strong>2009</strong> Q4 <strong>2009</strong> Q2 2010<br />

Q2 2005<br />

Q4 2005<br />

Q2 2006<br />

Q4 2006<br />

Q2 2007<br />

Q4 2007<br />

Q2 2008<br />

Q4 2008<br />

Q2 <strong>2009</strong><br />

Q4 <strong>2009</strong><br />

Q2 2010<br />

Value (bn)<br />

Source: unquote”<br />

Number and <strong>to</strong>tal value of 10m+ French buyouts per quarter.<br />

Source: unquote”<br />

Number and <strong>to</strong>tal value of European 10m+ buyouts per quarter<br />

12 UNQUOTE AUGUST/SEPTEMBER 10 ENTIRE CONTENTS COPYRIGHT 2010 INCISIVE MEDIA INVESTMENTS LTD<br />

www.unquote.com/france


Financial<br />

3/25/09 5:53:18 PM<br />

<br />

<br />

<br />

<br />

fxweek.com<br />

countries”.<br />

<br />

<br />

<br />

Sales head quits BarCap 2<br />

Athanasopoulos resigns<br />

FX bonuses down 60% 3<br />

Napier Sco t releases latest<br />

remuneration report<br />

Rabobank reshuffle 4<br />

Changes in structured products<br />

Cognotec tackles liquidity 6<br />

New liquidity management<br />

module launched<br />

Saxo Bank results 9<br />

Forex b osts income<br />

StreamBase 6.3 a rives 11<br />

Improved FX o fering from new<br />

CEP software<br />

<br />

<br />

<br />

May 2 09<br />

start of April.<br />

WWW.FINANCIALDIRECTOR.CO.UK<br />

declaration said.<br />

9<br />

8<br />

3/4/09 18:51:03<br />

Struggling <strong>to</strong><br />

keep up with<br />

the news?<br />

Look no further.<br />

With over 100 magazines, newsletters, journals and websites covering every<br />

Inc<strong>is</strong>ive Media provides you with the<br />

intelligence <strong>to</strong>olkit you need <strong>to</strong> succeed in <strong>to</strong>day’s changing markets.<br />

Inc<strong>is</strong>ive Media creates tailor-made packages <strong>to</strong> give you the edge.<br />

Call our information team and find out how a bespoke package will make your business work smarter<br />

LONDON<br />

Nicky on +44 (0)20 7968 4569<br />

or email him at<br />

nicky.hudson@inc<strong>is</strong>ivemedia.com<br />

watersonline.com<br />

APRIL <strong>2009</strong><br />

APRIL <strong>2009</strong> BUY VS. BUILD | FIX FOR FX | EXCEL RISK | ALGO TRADING | WATERS DEBATE<br />

Drastic<br />

Cutbacks<br />

Severely slashed IT budgets and headcounts<br />

force a shift in the buy-vs.-build argument.<br />

WATERS DEBATE<br />

Hire American?<br />

FIX for FX<br />

Tackling Excel R<strong>is</strong>k<br />

Technology<br />

Inte ligence<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

FX Week<br />

The global business o foreign exchange April 6 <strong>2009</strong> v.20 n.14<br />

G-20 plans global systemic r<strong>is</strong>k regime<br />

<br />

<br />

LONDON – A declaration by the Group of of the financial sec<strong>to</strong>r. They wi l also submi<br />

<strong>to</strong> regula<strong>to</strong>ry peer reviews. No details large hedge funds, which wi l be required<br />

impact on systemic r<strong>is</strong>k. Th<strong>is</strong> includes<br />

20 leading economies (G-20) fleshed out<br />

plans for a global regime of systemic r<strong>is</strong>k have emerged on when the FSB wi l be <strong>to</strong> reg<strong>is</strong>ter and supply information <strong>to</strong><br />

regulation, “covering regulated banks, establ<strong>is</strong>hed, what its exact responsibilities national regula<strong>to</strong>rs on questions such as<br />

shadow banks and private pools of capital<br />

the amount of leverage they employ. Any<br />

<strong>to</strong> limit the build-up of systemic r<strong>is</strong>k”.<br />

counterparties <strong>to</strong> trades with hedge funds<br />

A communiqué i sued after the group’s<br />

wi l be required <strong>to</strong> have e fective r<strong>is</strong>k management,<br />

se ting limits for single counter-<br />

London summit on April 2 said the plans<br />

would establ<strong>is</strong>h “much greater cons<strong>is</strong>tency<br />

and systemi co-operation betw en<br />

moni<strong>to</strong>r the leverage of the funds.<br />

party exposures and using mechan<strong>is</strong>ms <strong>to</strong><br />

To prevent regula<strong>to</strong>ry arbitrage, the FSB<br />

At the centre of the proposals lay plans<br />

wi l draw up guidelines <strong>to</strong> help national<br />

<strong>to</strong> increase the role of the Financial Stability<br />

Forum, which would be given<br />

stitutes a systemica ly-important financial<br />

authorities determine exactly what con-<br />

greater powers and renamed the Financial<br />

institution, market or instrument. “These<br />

Stability Board (FSB). Participating are and who it senior sta f wi l be. guidelines should focus on what institutions<br />

do rather than their legal form,” the<br />

countries – compr<strong>is</strong>ing the FSB’s cu rent Participating countries agr ed <strong>to</strong> amend<br />

members, plus Spain – wi l commit <strong>to</strong> thei regula<strong>to</strong>ry systems <strong>to</strong> encompass a l<br />

maintaining financial stability, and regulated banks, shadow banks and private<br />

pools of capital that might have an for co-operation between<br />

The FSB wi l also develop mechan<strong>is</strong>ms<br />

enhancing the openne s and transparency<br />

national<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

SEOUL – The International rates su fered significant<br />

Swaps and Derivatives A sociation<br />

(Isda) has a tacked tri lion won ($1.2 bi lion),<br />

losses, estimated <strong>to</strong> reach 1.7<br />

South Korean court rulings prompting them <strong>to</strong> sue the<br />

on FX ba rier options, for banks <strong>to</strong> have the contracts<br />

undermining the contractual cance led, also a cusing them<br />

commitments of the over-thecounter<br />

derivatives market. won has dropped 24% since<br />

of unfairness and fraud. The<br />

The cases involve FX knockin/knock-out<br />

(Kiko) options against the US do lar at the<br />

September 15 <strong>to</strong> reach 1,379<br />

contracts that Korean inves<strong>to</strong>rs<br />

bought between 2007 Dec<strong>is</strong>ions have been made in<br />

cus<strong>to</strong>mers <strong>to</strong> s<strong>to</strong>p-lo s.<br />

and last <strong>year</strong>, <strong>to</strong> protect them 11 cases, including four cases<br />

against won appreciation, where the Seoul Central D<strong>is</strong>trict<br />

Court ruled in favour of<br />

with many opting for the<br />

cheaper ba rier options. However,<br />

when the US do lar made a preliminary injunction due<br />

the companies, granting them<br />

a turnaround last <strong>year</strong>, corpo-<br />

<strong>to</strong> “changed circumstances”. the favourable dec<strong>is</strong>ion.<br />

In reviewing the cases, the<br />

courts considered whether the<br />

banks had fu ly d<strong>is</strong>closed the<br />

r<strong>is</strong>ks <strong>to</strong> cus<strong>to</strong>mers, the suitability<br />

of the products, the<br />

magnitude of losses incurred<br />

– relative <strong>to</strong> the financial<br />

strength of the company – and<br />

whether the banks had performed<br />

their duties <strong>to</strong> adv<strong>is</strong>e<br />

Citibank and Woori Bank<br />

have won the cases brought<br />

against them over advice <strong>to</strong><br />

clients about s<strong>to</strong>p lo ses, but<br />

Isda last Wednesday (April 1)<br />

attacked the reasoning behind<br />

NEW YORK<br />

Ceci on +1 212 457 7860 or email<br />

ceci.recalde@inc<strong>is</strong>ivemedia.com<br />

Inside<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

The G-20 countries agreed<br />

<strong>to</strong> amend thei regula<strong>to</strong>ry<br />

systems <strong>to</strong> encompass a l<br />

regulated banks, shadow<br />

banks and private pools of<br />

capital that might have an<br />

impact on systemic r<strong>is</strong>k<br />

<br />

Isda pans Korean courts over options rulings<br />

CCE S: FTSE-1 0 FDs AND THEIR INSTITUTES GR EN SHOOTS? OR PUSHING UP DAISIES? STOCK PRICES UP, RETAIL PRICES DOWN THANK YOU, DARLING<br />

FINANCIALDIRECTOR<br />

CREATIVE ACCOUNTANTS<br />

HOW TO SEE THE PICTURE<br />

BEHIND THE NUMBERS<br />

HONG KONG<br />

Roopam +852 3411 4837 or email<br />

Roopam@inc<strong>is</strong>ivemedia.com<br />

inc<strong>is</strong>ivemedia.com<br />

inc<strong>is</strong>ive-events.com


European round-up<br />

unquote<br />

Benelux unquote”<br />

June may have been rather sedate, but the Benelux region could soon witness its biggest deal in <strong>year</strong>s. TPG and Goldman Sachs’<br />

private equity wing are closing in on a 1.2bn deal <strong>to</strong> buy Belgian nappy maker Ontex from Candover. The bid originally<br />

stumbled when Goldman Sachs’ initial partner withdrew from the sale. However, TPG’s involvement put it back on track and the<br />

sale should be completed in the coming weeks.<br />

News was otherw<strong>is</strong>e scarce on the buyout front; Apax Partners agreed <strong>to</strong> acquire BNP Paribas’s Belgian personal finance arm for<br />

an und<strong>is</strong>closed amount. Meanwhile, Barclays Private Equity bought MPS Meat Processing Systems in a secondary buyout from<br />

Steadfast Capital.<br />

In the Netherlands, Gilde Buyout Partners closed its Gilde Buyout Fund IV on 800m. Launched in March <strong>2009</strong>, the vehicle<br />

will make equity investments of 25-200m in mid-market companies across a wide range of industries, with a core focus on the<br />

Benelux, German-speaking and French economies.<br />

Last but not least, all eyes could turn <strong>to</strong> Amsterdam if reports of an AlpInvest sale were <strong>to</strong> material<strong>is</strong>e. Owned by Dutch pension<br />

funds ABP and PGGM, AlpInvest <strong>is</strong> one of the largest European private equity firms. With more than 40bn under management,<br />

it special<strong>is</strong>es in fund investments, secondary investments, co-investments and mezzanine transactions.<br />

Deutsche unquote”<br />

The DACH region has seen a steady increase in activity across the board. Fundra<strong>is</strong>ing has seen its first recorded activity in a<br />

few months with Sw<strong>is</strong>s-based SAM Private Equity holding a first close on its cleantech fund-of-funds. Buyout activity has been<br />

reasonably prevalent, with a number of deals being closed in the last few weeks. HgCapital’s acqu<strong>is</strong>ition of Teufel Speakers from<br />

Riverside <strong>is</strong> a recent significant transaction.<br />

Another secondary buyout, Nordic Capital’s acqu<strong>is</strong>ition of German company SiC Processing, was one of the more prominent<br />

investments for the region. The value of the deal was not d<strong>is</strong>closed, but the acqu<strong>is</strong>ition gave exiting inves<strong>to</strong>r Frog Capital a 3x<br />

return on investment. Other deals of note include NORD Holding’s MBO of Uhlig Rohrbogen GmbH and Chequers Capital’s<br />

66m acqu<strong>is</strong>ition of Versatel Kabel.<br />

Early-stage and expansion deals in the DACH region have been highly active, with Earlybird accounting for three investments,<br />

in CrowdPark, B2X Care Solutions and ubitricity. Additionally, WHEB Ventures provided 4.4m in expansion funding for<br />

VIA Optronics.<br />

The exit window, which seems <strong>to</strong> have opened lately, has seen a few more deals close. Apart from the two exits included in the<br />

secondary buyouts already mentioned, Permira, Goldman Sachs Capital Partners and SV Life Sciences exited Cogn<strong>is</strong> in a trade<br />

sale <strong>to</strong> BASF. The exit gave a reported 3x return on investment for Permira.<br />

Nordic unquote”<br />

The Nordic market has once again proven <strong>to</strong> be a strong source for private equity activity. The number of deals has continuously<br />

grown in the first half of the <strong>year</strong>, as the Nordic region prepares for the summer holidays. There have been two fund closures in<br />

the last few weeks, with CapMan Buyout IX and the secondaries fund Cubera V reaching final close. Both funds will focus on the<br />

Nordic region.<br />

Chalmers Innovation led the increase in early-stage and expansion investments recorded by unquote”. A <strong>to</strong>tal of five investments<br />

have been reported by the inves<strong>to</strong>r in recent month. Other early-stage deals include Vækstfonden’s investment in biotech company<br />

En<strong>to</strong>moPharm and Norinnova’s backing of VIV<strong>is</strong>ion Roller. The largest expansion deal was for NOK 52m in resort opera<strong>to</strong>r<br />

14 UNQUOTE AUGUST/SEPTEMBER 10 ENTIRE CONTENTS COPYRIGHT 2010 INCISIVE MEDIA INVESTMENTS LTD<br />

www.unquote.com/france


unquote<br />

European round-up<br />

Målselv Utvikling. Other deals of note included two investments by Fouriertransform and Almi’s backing of Videofy.me.<br />

Buyout activity in the Nordic region has seen a large increase over the last few weeks. A <strong>to</strong>tal of eight buyouts were recorded,<br />

including Tri<strong>to</strong>n’s SEK 1.3bn MCS acqu<strong>is</strong>ition and Ra<strong>to</strong>s’ DKK 1.09bn S<strong>to</strong>fa buyout. CapMan’s acqu<strong>is</strong>ition of INR and Aspen<br />

was another high profile buyout.<br />

Exits have also seen an increase, with five having been recorded. One IPO has taken place, with CapMan’s partial exit of MQ.<br />

However, with the cancellation of EPiServer’s IPO, things haven’t been entirely rosy for the IPO market. It will be interesting <strong>to</strong><br />

see if the increasing activity will be maintained after summer.<br />

Southern Europe unquote”<br />

The number of deal completions in the Southern European buyout segment remains subdued, but there are signs that the debt<br />

market <strong>is</strong> open for business: although not yet a done deal, reports early in July suggested that the multi-billion-euro package<br />

of debt needed <strong>to</strong> support CVC’s buyout bid for Span<strong>is</strong>h infrastructure business Albert<strong>is</strong> had been approved. If the deal goes<br />

through it will value Albert<strong>is</strong> at around 25bn. Only two other buyouts – both smaller mid-cap acqu<strong>is</strong>itions – are known <strong>to</strong> have<br />

been completed since early June.<br />

In further bad news for buyout inves<strong>to</strong>rs in the region, the large banking syndicate holding debt in Span<strong>is</strong>h bakery business<br />

Panrico reached an agreement over a debt-for-equity swap, which sees backer Apax Partners losing the majority of its holding in<br />

the business.<br />

Outside of the buyout area, dealflow has also been scarce with just a handful of expansion and early-stage transactions being<br />

confirmed across the region. The most significant transaction came in the form of Ambienta’s 30m expansion capital investment<br />

in the Italian industrial cooling systems producer Spig SpA.<br />

Despite the gloomy deal conditions there <strong>is</strong> clearly some cause for optim<strong>is</strong>m as Madrid-based law firm Gómez-Acebo & Pombo<br />

recently announced its intention <strong>to</strong> create a new stand-alone private equity practice. The new group will provide a multid<strong>is</strong>ciplinary<br />

offering, encompassing M&A, tax, f<strong>is</strong>cal, fund structuring and regula<strong>to</strong>ry advice.<br />

UK & Ireland unquote”<br />

<strong>Although</strong> activity in the UK continued <strong>to</strong> be concentrated around the lower- <strong>to</strong> mid-market region, the market saw at least one<br />

deal exceed the £250m mark. The largest of the 14 deals in the buyout segment was TPG Capital’s £300m purchase of UK<br />

fashion retailer Republic from Change Capital Partners. Th<strong>is</strong> marked the third time the company had been backed by a private<br />

equity group, as inves<strong>to</strong>rs continue <strong>to</strong> view the fashion segment with high-growth expectations.<br />

Indeed fashion and entertainment seemed <strong>to</strong> be the flavour of the month, with Gala Coral finally completing its restructuring, as<br />

Apollo Management, Cerberus, Park Square and York Capital Management <strong>to</strong>ok over as equity inves<strong>to</strong>rs – replacing Candover,<br />

Cinven and Permira. The previous inves<strong>to</strong>rs are estimated <strong>to</strong> have lost about £670m on their original investment in the gaming<br />

company, after the mezzanine inves<strong>to</strong>rs swapped £558m of debt for equity, and injected £200m in new cash.<br />

The entertainment sec<strong>to</strong>r also saw CVC take a 28% stake in Merlin, boosting the expansion segment, which saw about 12 deals.<br />

Fashion was also en vogue in expansion, with Balder<strong>to</strong>n Capital investing $9m in UK online fashion retailer my-wardrobe.com;<br />

Advent Venture Partners investing $4.5m in online fashion company farfetch.com; and Key Capital Partners backing UK fashion<br />

company Fly53 with a £1m investment.<br />

Venture deal-making remained relatively subdued, seeing only two deals. The larger of the two was Finance Wales’s investment<br />

in software and computer services company, Altech Software. The company received funding <strong>to</strong> market its newly developed food<br />

processing software.<br />

ENTIRE CONTENTS COPYRIGHT 2010 INCISIVE MEDIA INVESTMENTS LTD UNQUOTE AUGUST/SEPTEMBER 10 15<br />

www.unquote.com/france


deal sec<strong>to</strong>r index<br />

unquote<br />

DEALS<br />

VALUE<br />

(M)<br />

TYPE NAME LEAD BACKERS REGION PAGE<br />

AUTO PARTS n/d MBO Groupe ACR EQUITY: Nextstage<br />

DEBT: LCL, SocGen<br />

Gennevilliers 27<br />

BIOTECHNOLOGY 16m Early-stage Poxel EQUITY: EdRIP Lyon 17<br />

BUILDING<br />

MATERIALS AND<br />

FIXTURES<br />

CLOTHING<br />

ACCESSORIES<br />

CONTAINERS AND<br />

PACKAGING<br />

FINANCIAL<br />

ADMINISTRATION<br />

INDUSTRIAL<br />

SUPPLIERS<br />


unquote<br />

early-stage<br />

Early-stage transactions include start-up/seed and early-stage equity investments. Start-up/seed financing <strong>is</strong> provided <strong>to</strong> companies for use<br />

in product development and initial marketing. Companies may be in the process of being set up or may have been in business for a short<br />

time, but have not sold their product commercially. Early-stage financing allows companies which have completed the product development<br />

stage and require further funds <strong>to</strong> initiate commercial manufacturing and sales. They may not yet be generating any revenues.<br />

EdRIP et al. invest 16m in Poxel<br />

Transaction<br />

Edmond de Rothschild Investment Partners (EdRIP), CDC Entrepr<strong>is</strong>es and Crédit Agricole Private<br />

Equity have provided drugs developer Poxel with a 16m series-A round of financing.<br />

EdRIP contributed 8m <strong>to</strong> the round via its Biod<strong>is</strong>covery 3 FCPR, Partenariat & Innovation 2 FCPI<br />

and Partenariat & Innovation 3 FCPI funds. CDC invested 5m via the InnoBio fund, a vehicle it <strong>is</strong><br />

managing on behalf of the state-backed Fonds Stratégique d’Invest<strong>is</strong>sement.<br />

EARLY-STAGE<br />

Poxel<br />

16m<br />

Location Lyon<br />

Sec<strong>to</strong>r Biotechnology<br />

Founded <strong>2009</strong><br />

Staff 7<br />

The remaining 3m was provided by Crédit Agricole PE. Th<strong>is</strong> transaction <strong>is</strong> the largest French series-A<br />

round of funding since 2005.<br />

Poxel will use the new funds <strong>to</strong> accelerate the development and clinical testing of its most advanced<br />

product, Imeglimine, designed <strong>to</strong> treat type-2 diabetes.<br />

Company<br />

Poxel span out from Merck Serono in <strong>2009</strong>. It develops anti-diabetic molecules, focusing particularly on<br />

treatment for type-2 diabetes. Poxel’s pipeline cons<strong>is</strong>ts of innovative products with original mechan<strong>is</strong>m<br />

of action, with an improved safety profile compared <strong>to</strong> currently available therapies. Based in Lyon,<br />

Poxel currently employs seven people.<br />

People<br />

Raphael W<strong>is</strong>niewski led the deal for EdRIP. CDC was represented by Thibaut Roulon. Bruno Montanari<br />

handled the transaction for Crédit Agricole. W<strong>is</strong>niewski and Montanari will join Poxel’s board, along<br />

with Olivier Martinez from the InnoBio fund. Thomas Kuhn <strong>is</strong> CEO of Poxel.<br />

Adv<strong>is</strong>ers<br />

Equity – Orsay, Frédéric Lerner, Lou<strong>is</strong> d’Urzo (Legal); HBC Avocats, Jonathan Burnham (Legal);<br />

Adwelsen, Florent Béliard (Financial due diligence); Régimbeau, Isabelle Mendelsohn (Intellectual<br />

property due diligence).<br />

Company – Bignon Lebray, Guy de Foresta (Legal); Bionest (Other due diligence).<br />

Sofinnova et al. back McPhy with 13.7m<br />

Transaction<br />

Sofinnova Partners, Gimv and Amundi Private Equity have backed McPhy Energy with a 13.7m<br />

second round of funding, alongside h<strong>is</strong><strong>to</strong>ric inves<strong>to</strong>rs.<br />

The company had already ra<strong>is</strong>ed a 1.6m first round of financing in January <strong>2009</strong> from Emertec and<br />

Areva. The new funds will be used for the global expansion of McPhy and the further industrial<strong>is</strong>ation<br />

and commercial<strong>is</strong>ation of its products. Already present in Spain and Italy, the company also plans <strong>to</strong><br />

expand in<strong>to</strong> Germany, northern Europe, the Middle East and Japan.<br />

EARLY-STAGE<br />

McPhy Energy<br />

13.7m<br />

Location La Motte-Fanjas<br />

Sec<strong>to</strong>r Renewable<br />

energy<br />

equipment<br />

Founded 2008<br />

ENTIRE CONTENTS COPYRIGHT 2010 INCISIVE MEDIA INVESTMENTS LTD UNQUOTE AUGUST/SEPTEMBER 10 17<br />

www.unquote.com/france


early-stage<br />

unquote<br />

McPhy’s cleantech focus was a major attraction for the inves<strong>to</strong>rs. The deal marks Sofinnova’s fourth<br />

investment in th<strong>is</strong> sec<strong>to</strong>r, following its funding of DNP Green, Revolt Technology and Neosens.<br />

All contribu<strong>to</strong>rs <strong>to</strong> th<strong>is</strong> round believe solid state hydrogen s<strong>to</strong>rage will address the crucial <strong>is</strong>sue of<br />

sustainable energy s<strong>to</strong>rage.<br />

Company<br />

McPhy <strong>is</strong> a French company founded in January 2008 <strong>to</strong> industrial<strong>is</strong>e and commercial<strong>is</strong>e a new<br />

technology for the solid s<strong>to</strong>rage of hydrogen, in the form of magnesium hydride. The technology<br />

addresses the merchant hydrogen and renewable energy markets.<br />

McPhy owns exclusive rights on a portfolio of unique patents, which results from more than eight <strong>year</strong>s<br />

of research at the CNRS and CEA, in partnership with Joseph Fourier University.<br />

People<br />

Alessio Beverina led the deal for Sofinnova. Bart Diels handled the transaction for Gimv. Florent<br />

Thomann represented Amundi PEF. Pascal Mauberger <strong>is</strong> CEO of McPhy.<br />

Adv<strong>is</strong>ers<br />

Company – Clipper<strong>to</strong>n Finance, Nicolas von Bulow, Thomas Neveux (M&A).<br />

EARLY-STAGE<br />

EyeTechCare<br />

7.5m<br />

Location<br />

Sec<strong>to</strong>r<br />

Founded 2008<br />

Staff 7<br />

Rillieux-la-Pape<br />

Medical<br />

equipment<br />

Crédit Agricole et al. in 7.5m EyeTechCare deal<br />

Transaction<br />

Crédit Agricole Private Equity and insurance company SHAM have provided medical devices developer<br />

EyeTechCare with a 7.5m round of funding.<br />

Crédit Agricole led the round with 4.5m, while SHAM invested 3m. EyeTechCare had already<br />

ra<strong>is</strong>ed 1.2m in 2008 from Crédit Agricole and CEA-Invest<strong>is</strong>sement. The new funds will be used <strong>to</strong><br />

complete the initial clinical trials on humans, as well as <strong>to</strong> establ<strong>is</strong>h the manufacturing facilities and sales<br />

and marketing force required for the company’s first product.<br />

The inves<strong>to</strong>rs believe EyeTechCare’s solution will respond <strong>to</strong> unmet needs in the treatment of glaucoma.<br />

Crédit Agricole, which has been following the company since its inception, was particularly impressed<br />

with the management team’s progress over the last two <strong>year</strong>s.<br />

Company<br />

EyeTechCare was founded in 2008 and <strong>is</strong> based in Rillieux-la-Pape, near Lyon. With a staff of seven<br />

researchers, it special<strong>is</strong>es in non-invasive therapeutic medical devices using ultrasound technology. The<br />

company <strong>is</strong> currently developing an ultrasound-based medical device for the treatment of glaucoma; its<br />

market launch <strong>is</strong> scheduled for early 2011.<br />

People<br />

Alexia Perouse handled the transaction for Crédit Agricole. Olivier Szymkowiak represented SHAM.<br />

Fabrice Romano <strong>is</strong> the chairman of EyeTechCare.<br />

Adv<strong>is</strong>ers<br />

Equity – Morgan Lew<strong>is</strong> Bockius (Legal).<br />

Company – MAGS (Legal); Aelios Finance (Corporate finance).<br />

18 UNQUOTE AUGUST/SEPTEMBER 10 ENTIRE CONTENTS COPYRIGHT 2010 INCISIVE MEDIA INVESTMENTS LTD<br />

www.unquote.com/france


unquote<br />

expansion<br />

Expansion capital <strong>is</strong> provided <strong>to</strong> support the growth and expansion of an establ<strong>is</strong>hed company and must include an element of equity financing.<br />

Funds may be used <strong>to</strong> enable increased production capacity, market or product development and/or <strong>to</strong> provide additional working capital.<br />

Acqu<strong>is</strong>ition finance provided <strong>to</strong> a new or ex<strong>is</strong>ting investee company <strong>to</strong> support its acqu<strong>is</strong>ition of a target or targets <strong>is</strong> also included in th<strong>is</strong> section.<br />

Butler invests 15m in Chr<strong>is</strong>tian Bernard<br />

Transaction<br />

Butler Capital has invested 15m in French jeweller Groupe Chr<strong>is</strong>tian Bernard, acquiring slightly less<br />

than 50% of the company.<br />

The company’s founding shareholders retain the remaining stake. Butler was attracted by Chr<strong>is</strong>tian<br />

Bernard’s position in the French jewellery market. The fresh capital will be used <strong>to</strong> accelerate the<br />

company’s international expansion.<br />

Company<br />

Chr<strong>is</strong>tian Bernard was founded in 1973 and launched its first collection in 1976. The company<br />

designs, manufactures and d<strong>is</strong>tributes watches and jewellery under its own name and through licensing<br />

partnerships. In 2005, the company purchased the retail chain Oro Vivo <strong>to</strong> directly sell its products in<br />

Germany, Switzerland, Spain and Portugal. Chr<strong>is</strong>tian Bernard has also expanded <strong>to</strong> Asia <strong>to</strong> manufacture<br />

some of its products and d<strong>is</strong>tribute them in local markets.<br />

EXPANSION<br />

Groupe Chr<strong>is</strong>tian<br />

Bernard<br />

15m<br />

Location Par<strong>is</strong><br />

Sec<strong>to</strong>r Clothing &<br />

accessories<br />

Founded 1973<br />

Turnover 150m (<strong>2009</strong>)<br />

Staff c4,000<br />

The group currently employs 4,000 staff and posted a 150m turnover in <strong>2009</strong>, 60% of which was<br />

generated outside of France. More than half of its sales are made through wholesale, while 45% <strong>is</strong><br />

through the retail market.<br />

People<br />

Pierre Costes and Frédéric Favreau led the deal for Butler. Damien Verrier <strong>is</strong> chief executive of Chr<strong>is</strong>tian<br />

Bernard.<br />

Adv<strong>is</strong>ers<br />

Equity – CGR Legal, Philippe Raybaud (Legal); Duff & Phelps, Sophie Moreau, Cédric Hetzel<br />

(Financial due diligence).<br />

Company – Murène, Dinah Emsalem (M&A); UGGC, Charles-Emmanuel Prieur, Laura Malach<br />

(Legal).<br />

123Venture invests in Redman Promotion<br />

Transaction<br />

123Venture has provided real estate company Redman Promotion with a first round of fundra<strong>is</strong>ing.<br />

The size of the investment has not been d<strong>is</strong>closed, but has been confirmed as less than 10m. The<br />

funds will be used <strong>to</strong> create two new subsidiaries for Redman – one focused on office buildings and<br />

the other on residential housing – with the ambition of launching 10 additional real estate operations.<br />

123Venture saw potential in Redman’s project due <strong>to</strong> a shortage of housing in France.<br />

EXPANSION<br />

Redman Promotion<br />


expansion<br />

unquote<br />

marketing and negotiation ass<strong>is</strong>tance. While th<strong>is</strong> <strong>is</strong> done for external promoters, Redman also manages<br />

its own portfolio through its Promotion branch. Operating out of Par<strong>is</strong> and Aix-en-Provence, Redman<br />

employs 12 people and generated a turnover of 5m in <strong>2009</strong>.<br />

People<br />

Eric Philippon handled the investment for 123Venture. Nicolas Ponson <strong>is</strong> founding partner and<br />

manager of Redman.<br />

Adv<strong>is</strong>ers<br />

Equity – Reed Smith, Stéphane Illouz (Legal).<br />

EXPANSION<br />

Oxat<strong>is</strong><br />

4m<br />

Location Marseilles<br />

Sec<strong>to</strong>r Internet<br />

Founded 2001<br />

Staff 40<br />

Crédit Agricole PE et al. invest 4m in Oxat<strong>is</strong><br />

Transaction<br />

Crédit Agricole Private Equity and A Plus Finance have provided 4m for e-commerce solutions<br />

provider Oxat<strong>is</strong>. Crédit Agricole PE will provide 2.5m, while previous inves<strong>to</strong>r A Plus Finance will<br />

give a further 1.5m. A Plus previously invested 1.33m in the company in 2008.<br />

The new funds will be used <strong>to</strong> enhance Oxat<strong>is</strong>’ software platform and offer its programme <strong>to</strong> other<br />

relevant businesses. The company also plans <strong>to</strong> quickly bolster its team, from 40 staff <strong>to</strong> more than<br />

100. The Crédit Agricole team was attracted by Oxat<strong>is</strong>’ product and the robustness of its business<br />

model. It also believes Oxat<strong>is</strong> caters <strong>to</strong> a growing need among French SMEs <strong>to</strong> set up their own<br />

merchant sites.<br />

Company<br />

Establ<strong>is</strong>hed in 2001 by Marc Schillaci, Oxat<strong>is</strong> provides cloud-computing e-commerce platforms<br />

for around 6,500 clients. Its technology enables SMEs, craftsmen and merchants <strong>to</strong> incorporate e-<br />

commerce software in<strong>to</strong> their websites. The company also enables businesses <strong>to</strong> get started on the<br />

internet and sell more without large set-up costs and long-term contracts. One in three e-commerce<br />

websites in France uses the Oxat<strong>is</strong> platform.<br />

People<br />

Renaud Poulard and Franco<strong>is</strong>-Xavier Dedde led the deal for Crédit Agricole. A Plus was represented<br />

by Niels Court-Payen, Jean-Michel Pimont and Alexandre Villet. Marc Schillaci <strong>is</strong> chairman of Oxat<strong>is</strong>’<br />

executive board.<br />

EXPANSION<br />

Nuxeo<br />

$3.3m<br />

Location Par<strong>is</strong><br />

Sec<strong>to</strong>r Software<br />

Founded 2000<br />

Turnover 3m<br />

Adv<strong>is</strong>ers<br />

Equity – Gide Loyrette Nouel, Pierre Karpik (Legal); Ernst & Young, Emmanuel Picard, Franco<strong>is</strong><br />

Poncet (Financial due diligence).<br />

Company – Kahn & Associés, Marie-Laure de Cordovez (Legal); Global Equities, Pascal Mercier,<br />

Guillaume Teboul (Corporate finance).<br />

OTC injects $3.3m in<strong>to</strong> Nuxeo<br />

Transaction<br />

OTC Asset Management has provided content management solutions provider Nuxeo with $3.3m.<br />

OTC previously invested $2.6m in late 2008, for a 41% stake in the company. The private equity house<br />

20 UNQUOTE AUGUST/SEPTEMBER 10 ENTIRE CONTENTS COPYRIGHT 2010 INCISIVE MEDIA INVESTMENTS LTD<br />

www.unquote.com/france


unquote<br />

expansion<br />

renewed its backing after a successful launch in North America and says it <strong>is</strong> convinced by Nuxeo’s<br />

business model and positioning.<br />

The new capital will support a range of partner activities, such as funding co-development of thirdparty<br />

packaged applications, sharing Nuxeo’s engineering and services resources, and joint marketing<br />

and product launch activities. Nuxeo also plans <strong>to</strong> continue its expansion in North America with the<br />

hire of staff responsible for managing and expanding the Nuxeo Galaxy partner programme.<br />

Company<br />

Nuxeo <strong>is</strong> a provider of open-source content management solutions. It <strong>is</strong> headquartered in Par<strong>is</strong>, with<br />

offices in Bos<strong>to</strong>n, Madrid, Rome, Moscow and Dubai, and used by hundreds of companies worldwide,<br />

including the Press Association, Agence France Presse (AFP), Ell<strong>is</strong>Don and Cengage. The company<br />

generates revenue from its Nuxeo Galaxy partner programme, compr<strong>is</strong>ed of systems integra<strong>to</strong>rs,<br />

consultants and application solution providers who build content-centric applications on the company’s<br />

open-source technology. Founded in 2000, Nuxeo posted a 3m turnover for <strong>2009</strong>.<br />

People<br />

Patrick de Roquemaurel led the transaction for OTC and sits on the Nuxeo board. Eric Barroca <strong>is</strong> the<br />

CEO of Nuxeo.<br />

Adv<strong>is</strong>ers<br />

Equity – Gide Loyrette Nouel, Pierre Karpik (Legal).<br />

Company – Cabinet Joffe et Associés, Virginie Belle (Legal).<br />

BNP Paribas backs Acropol<strong>is</strong> with 1.8m<br />

Transaction<br />

BNP Paribas Private Equity has invested a further 1.8m in French telecoms opera<strong>to</strong>r Acropol<strong>is</strong><br />

Telecom. Th<strong>is</strong> <strong>is</strong> the second time BNP Paribas has backed the company, having initially invested<br />

700,000 in May <strong>2009</strong>.<br />

EXPANSION<br />

Acropol<strong>is</strong> Telecom<br />

1.8m<br />

Location Bagnolet<br />

Sec<strong>to</strong>r Internet<br />

Founded 2001<br />

Turnover 5m<br />

Staff 42<br />

The equity was drawn from Antin Proximité 1, Antin Proximité 2 and Antin Proximité 3 funds.<br />

The fresh capital will allow the company <strong>to</strong> continue its growth plans, including acqu<strong>is</strong>itions in the<br />

French market in order <strong>to</strong> increase its national presence. Additionally, Acropol<strong>is</strong> will look <strong>to</strong> grow<br />

organically by focusing on its offerings in the field of fixed and mobile telephony convergence and IT,<br />

as well as unified mail services.<br />

Company<br />

Establ<strong>is</strong>hed in 2001 by Samie Koleilat, Acropol<strong>is</strong> <strong>is</strong> a private network opera<strong>to</strong>r that focuses on corporate<br />

VPN MPLS and voice-over IP services.<br />

The company also offers internet access via both LAN and WAN, as well as security applications including<br />

firewalls, filters and anti-virus detec<strong>to</strong>rs. The business has partnerships with the likes of Cegetel, T Systems<br />

and France Telecom, and cus<strong>to</strong>mers in London, Amsterdam and Frankfurt. With a workforce of 42<br />

people, the company generated a turnover of 5m in <strong>2009</strong> – an increase of 25% on the previous <strong>year</strong>.<br />

People<br />

Managing partner Brice Lionnet and associate Laurent Bodino handled the investment for BNP Paribas.<br />

ENTIRE CONTENTS COPYRIGHT 2010 INCISIVE MEDIA INVESTMENTS LTD UNQUOTE AUGUST/SEPTEMBER 10 21<br />

www.unquote.com/france


expansion<br />

unquote<br />

Adv<strong>is</strong>ers<br />

Equity – CPNC Avocats, Nicolas Chaigneau (Legal)<br />

EXPANSION<br />

Novapost<br />

1.7m<br />

Location<br />

Sec<strong>to</strong>r<br />

Founded 2007<br />

Staff 20<br />

Par<strong>is</strong><br />

Financial<br />

admin<strong>is</strong>tration<br />

Alven Capital et al. back Novapost with 1.7m<br />

Transaction<br />

Alven Capital, Fa Dièse and four individual inves<strong>to</strong>rs have injected 1.7m in<strong>to</strong> electronic HR solutions<br />

provider Novapost.<br />

The stakes taken by each contribu<strong>to</strong>r remain und<strong>is</strong>closed. It <strong>is</strong> the first investment Alven has made in<br />

Novapost, while business angels Gérard Pluvinet, Pierre Kosciusko-Morizet, Bruno Gueninand and<br />

Jean-Paul Villot are all ex<strong>is</strong>ting shareholders.<br />

Alven Capital was attracted by Novapost’s recent commercial achievements and its position in a<br />

growing market. The company has taken advantage of a recently-introduced French law that legal<strong>is</strong>ed<br />

the dematerial<strong>is</strong>ation of admin<strong>is</strong>trative documents. Following the investment, Novapost will look <strong>to</strong><br />

diversify its activity.<br />

Company<br />

Novapost, created in 2007, offers companies and individuals an alternative <strong>to</strong> paper mail and paper<br />

archives through a 100% electronic mailing system, guaranteeing the legal value of HR documents. By<br />

using the latest SaaS (Software as a Service) platform technologies, Novapost guarantees the security,<br />

traceability and 24/7 access <strong>to</strong> the clients’ key documents.<br />

The company has recently signed contracts with businesses such as M6, Athome, Canal+, Officeo,<br />

Groupe Batigère, Ub<strong>is</strong>oft, PriceMin<strong>is</strong>ter and Veolia Propreté, as well as set up partnerships with e-Paye,<br />

HR Path and De Gamma.<br />

People<br />

Charles Le<strong>to</strong>urneur was in charge of the investment for Alven. Jonathan Benamou <strong>is</strong> the chairman and<br />

founder of Novapost.<br />

Adv<strong>is</strong>ers<br />

Equity – Didier & Levy, Thierry Levy-Mannheim (Legal); Oder<strong>is</strong> Consulting, Guillaume Lauilhé,<br />

Vincent Texier (Financial due diligence).<br />

Company – FTPA, Nathalie Younan (Legal).<br />

EXPANSION<br />

Devederm<br />

1.4m<br />

Location<br />

Charbonnièresles-Bains<br />

Personal products<br />

Sec<strong>to</strong>r<br />

Founded 2008<br />

Turnover 1m (<strong>2009</strong>)<br />

Staff 30<br />

Viver<strong>is</strong> et al. inject 1.4m in<strong>to</strong> Devederm<br />

Transaction<br />

Viver<strong>is</strong> Management and Promelys Participations have co-led a 1.4m round of fundra<strong>is</strong>ing for<br />

cosmetics company Devederm. Viver<strong>is</strong> and Promelys contributed 500,000 each, while Vatel Capital<br />

provided 107,000. The remainder of the round was funded by business angels.<br />

The new funds will be used <strong>to</strong> fuel the company’s organic growth by expanding the range<br />

of products on offer and by targeting more retailers. Devederm <strong>is</strong> also looking <strong>to</strong> expand its<br />

operations across Europe in the near future. By implementing th<strong>is</strong> strategy, the company <strong>is</strong> aiming<br />

22 UNQUOTE AUGUST/SEPTEMBER 10 ENTIRE CONTENTS COPYRIGHT 2010 INCISIVE MEDIA INVESTMENTS LTD<br />

www.unquote.com/france


unquote<br />

expansion<br />

for its products <strong>to</strong> be d<strong>is</strong>tributed by 350 retailers (up from 250) and <strong>to</strong> become profitable by the<br />

end of the <strong>year</strong>.<br />

Company<br />

Devederm was co-founded in 2008 by two former employees of rival cosmetics company Bioderma.<br />

The company manufactures and d<strong>is</strong>tributes the Terra Humana brand of cosmetic products across 250<br />

pharmacies in France. Devederm sources organic and fair-trade ingredients <strong>to</strong> manufacture more than<br />

20 different products.<br />

Based in Charbonnières-les-Bains, near Lyon, Devederm currently employs 30 people and has posted<br />

a 1m turnover for <strong>2009</strong>.<br />

People<br />

El<strong>is</strong>abeth Bertelli, Bruno Paglia and Sophie Gaddacha led the deal for Viver<strong>is</strong>. Hervé Le<strong>to</strong>ublon and<br />

Luc Chermette handled the transaction for Promelys. Franco<strong>is</strong> Gerber and An<strong>to</strong>ine Herbinet were in<br />

charge of the deal at Vatel. Thierry Le Morvan <strong>is</strong> CEO of Devederm.<br />

Adv<strong>is</strong>ers<br />

Company & Equity – Cabinet Colbert, Den<strong>is</strong> Simon, Cécile Dessapt (Legal); Canny Cap, Jean<br />

de la Rochebrochard, Guillaume Anselin (Corporate finance); Avvens, Jean-Pierre Lazaro (Financial<br />

due diligence).<br />

ISAI et al. invest 1.25m in Covoiturage.fr<br />

Transaction<br />

ISAI and a Span<strong>is</strong>h individual inves<strong>to</strong>r have backed Comu<strong>to</strong>, which runs carpooling website Covoiturage.<br />

fr, with 1.25m. ISAI provided the majority of the equity.<br />

Th<strong>is</strong> <strong>is</strong> the maiden investment from ISAI’s first fund, ISAI Developpement. The vehicle reached its first<br />

close at 24m in April 2010. It was mainly backed by internet and software entrepreneurs, as well as<br />

some institutional inves<strong>to</strong>rs. ISAI aims <strong>to</strong> make 12 investments over a four-<strong>year</strong> period.<br />

EXPANSION<br />

Comu<strong>to</strong> (edi<strong>to</strong>r of<br />

Covoiturage.fr)<br />

1.25m<br />

Location Par<strong>is</strong><br />

Sec<strong>to</strong>r Internet<br />

Founded 2006<br />

Staff 15<br />

The new capital combined with ISAI’s involvement will help the company grow in France and Spain.<br />

Covoiturage.fr <strong>is</strong> also looking in<strong>to</strong> various expansion opportunities, including further international<br />

deployment, diversification of its online services and strengthening of its B2B activities.<br />

Company<br />

Launched in 2004, Covoiturage.fr <strong>is</strong> a website that connects users looking for carpooling opportunities.<br />

Initially a side-project for its founders, the website became a corporate entity called Comu<strong>to</strong> in 2006.<br />

Travellers can input the details of their planned trip and contact drivers available for car-sharing who<br />

match those requirements.<br />

The website also acts as a social network where users can share their carpooling s<strong>to</strong>ries, post pictures<br />

and rate each other. Covoiturage.fr recently launched a mobile application, and <strong>to</strong>day represents 80%<br />

of all online carpooling ads in France with 600,000 reg<strong>is</strong>tered users.<br />

People<br />

Didier Kuhn and Pierre-Kosciusko-Morizet led the deal for ISAI. They are joining the company’s<br />

strategic committee. Frédéric Mazzella <strong>is</strong> the founder of Covoiturage.fr.<br />

ENTIRE CONTENTS COPYRIGHT 2010 INCISIVE MEDIA INVESTMENTS LTD UNQUOTE AUGUST/SEPTEMBER 10 23<br />

www.unquote.com/france


expansion<br />

unquote<br />

EXPANSION<br />

FInteractive<br />

500,000<br />

Location Lyon<br />

Sec<strong>to</strong>r Media agencies<br />

Founded 2007<br />

Turnover 600,000 (2008)<br />

Staff 11<br />

Adv<strong>is</strong>ers<br />

Equity – Gide Loyrette Nouel, Annabelle Raguenet de Saint Albin (Legal); 2C Finance, Frank<br />

Chuffard (Financial due diligence); Proskauer, Etienne Mathey (Tax).<br />

Company – Mo<strong>is</strong>and Boutin & Associés, Jean-Philippe Jacob, Harold Forestier (Legal); Carbonnier<br />

Lamaze Rasle & Associés, Charles Delavenne (Legal).<br />

Vatel supports FLInteractive with 500,000<br />

Transaction<br />

Vatel Capital has injected 500,000 of equity in<strong>to</strong> French online marketing agency FLInteractive. The<br />

company’s founder and management retain a majority stake, and Vatel’s stake has not been d<strong>is</strong>closed.<br />

The funds will be used <strong>to</strong> sustain the business’s growth by acquiring new clients and studying possible<br />

acqu<strong>is</strong>ition opportunities, with the aim of becoming a strong player in the free online gaming market.<br />

The deal was initiated through Canny Cap on behalf of the company.<br />

Company<br />

FLInteractive focuses its core activity on website publ<strong>is</strong>hing and online marketing. It offers a range of<br />

solutions for qualified database acqu<strong>is</strong>ition, co-reg<strong>is</strong>tration services, emailing campaigns and cost-perclick<br />

marketing. Founded in 2007 by Frédéric Lampin and Guillaume Ferrand, the company currently<br />

employs 11 staff and <strong>is</strong> based in Lyon.<br />

People<br />

Franco<strong>is</strong> Gerber and An<strong>to</strong>ine Herbinet handled the transaction for Vatel. Frédéric Lampin and<br />

Guillaume Ferrand are the founders and managers of FLInteractive.<br />

EXPANSION<br />

Intégral Système<br />


unquote<br />

expansion<br />

The company <strong>is</strong> based in Emerainville and employs 20 staff. It posted a 4.2m turnover in <strong>2009</strong>, up<br />

2% from the previous <strong>year</strong>.<br />

People<br />

Isabelle Galamand-Patard represented Avenir on the transaction. Stéphane Mélinand-Jégou <strong>is</strong> CEO of<br />

Intégral Système.<br />

Adv<strong>is</strong>ers<br />

Equity – PDGB, Roy Arakelian, Madia Iliopoulos (Legal).<br />

Company – Cabinet Quesnel-Hesters, Nicole Quesnel-Hesters (Legal).<br />

AXA’s Kall<strong>is</strong>ta Energy acquires four windfarms<br />

Transaction<br />

Kall<strong>is</strong>ta Energy has acquired the Brittany wind farm assets of Neoelectra, with the support of AXA<br />

Private Equity. The amount of expansion capital provided by AXA remains confidential.<br />

AXA wholly acquired Kall<strong>is</strong>ta Energy (formerly Holding Energies Renouvelables) from Babcock &<br />

Brown in <strong>2009</strong>, for an estimated value of 100-250m. The acqu<strong>is</strong>ition consolidates Kall<strong>is</strong>ta’s position in<br />

the French market, by increasing the number of its wind farms from 15 <strong>to</strong> 19 and its installed capacity <strong>to</strong><br />

194.5 MW. It also allows the company <strong>to</strong> be present in Brittany, a region with a particularly high potential<br />

for wind-produced energy.<br />

ACQUISITION FINANCE<br />

Kall<strong>is</strong>ta Energy<br />

Location Par<strong>is</strong><br />

Sec<strong>to</strong>r Renewable<br />

energy<br />

equipment<br />

Founded <strong>2009</strong><br />

Turnover 26.1m (<strong>2009</strong>)<br />

Staff 10<br />

Company<br />

Kall<strong>is</strong>ta Energy was founded in <strong>2009</strong> when AXA wholly acquired Kall<strong>is</strong>ta Energies Renouvelables<br />

(formerly Eners<strong>is</strong> Energies Renouvelables) and Kall<strong>is</strong>ta France (formerly Eners<strong>is</strong> France). The two<br />

companies were held through Holding Energies Renouvelables, which was renamed Kall<strong>is</strong>ta Energy in<br />

November <strong>2009</strong>. The company manufactures and operates wind farms.<br />

Based in Par<strong>is</strong>, the business has a significant presence in the A<strong>is</strong>ne/Picardie, Beauce and Seine-Maritime<br />

regions. With a 10-strong workforce, Kall<strong>is</strong>ta Energy posted a 26.1m turnover in <strong>2009</strong>.<br />

People<br />

Mathias Burghardt led the deal for AXA. Frédéric Roche <strong>is</strong> the CEO of Kall<strong>is</strong>ta Energy.<br />

Adv<strong>is</strong>ers<br />

Acquirer – CGR Legal, Florence Trognon-Dumain (Legal); Linklaters, Edouard Chapellier<br />

(Financial due diligence); Exco A2A, Franck Huyghe (Tax).<br />

Vendor – Freshfields Bruckhaus Deringer, Bertrand Pellet, Gabriel Flandin, Basma Paradin (Legal);<br />

Natix<strong>is</strong> Finance, Emmanuel Antmann (M&A).<br />

www.unquote.com/france<br />

The new home of private equity news, data and analys<strong>is</strong><br />

ENTIRE CONTENTS COPYRIGHT 2010 INCISIVE MEDIA INVESTMENTS LTD UNQUOTE AUGUST/SEPTEMBER 10 25<br />

www.unquote.com/france


uyouts<br />

unquote<br />

Leveraged buyouts and buy-ins involving equity investments by formal<strong>is</strong>ed private equity inves<strong>to</strong>rs through the formation of a newco based<br />

in France.<br />

SECONDARY BUYOUT<br />

Thermocoax<br />

Location Flers<br />

Sec<strong>to</strong>r Industrial<br />

suppliers<br />

Founded 1957<br />

Turnover 35m<br />

Staff 200<br />

Chequers buys Thermocoax back from TCR<br />

Transaction<br />

Chequers Capital has purchased a 60% stake in heating technology special<strong>is</strong>t Thermocoax from TCR<br />

Capital for an und<strong>is</strong>closed amount.<br />

TCR retains a 30% stake in the business through its TCR Capital Partners II fund. The remaining 10%<br />

of the shares are now owned by the management team, led by CEO Claude Capron.<br />

Th<strong>is</strong> represents the fourth time the company has been acquired by a private equity inves<strong>to</strong>r.<br />

Debt<br />

A 35m senior debt was co-led by CIC and LCL, with the support of BCME and Banques Populaires<br />

de l’Ouest. Indigo arranged the 11m mezzanine facility.<br />

Previous funding<br />

In 1998, Thermocoax was initially sold <strong>to</strong> Advent International by Phillips Electronics as part of the<br />

divestiture of a larger div<strong>is</strong>ion. Chequers backed the management buyout of the company in 2000 <strong>to</strong><br />

gain a 75% shareholding. TCR then acquired 85% of the firm in 2005 for an estimated 35m. The<br />

latest sale sees TCR reap an estimated 5x on its 2005 investment.<br />

Under TCR’s ownership, the company has expanded internationally and now operates out of Germany,<br />

the UK, the Netherlands and the US. It has also diversified its product offering <strong>to</strong> generate growth<br />

across a range of different industries.<br />

Company<br />

Thermocoax span out from Philips Electronics in 1957 under the name of SODERN (Société Anonyme<br />

d’Etudes & Réal<strong>is</strong>ations Nucléaires) <strong>to</strong> market Thermocoax branded products <strong>to</strong> the nuclear industry.<br />

In 1982, the company opened a plant in Planquivon, Normandy, and was renamed Thermocoax.<br />

It currently designs and manufactures heating systems and temperature sensors, targeting nuclear<br />

energy and aeronautical applications, as well as semi-conduc<strong>to</strong>r and medical equipment manufacturers.<br />

With a 200-strong staff, Thermocoax posted a 35m turnover for <strong>2009</strong>, 80% of which comes from<br />

international markets.<br />

People<br />

Guillaume Planchon and Aurélien Klein led the deal for Chequers. David Robin, Chr<strong>is</strong>tian Dorléac and<br />

Fabien Bernez represented TCR on the transaction. David Robin will keep h<strong>is</strong> seat on the company’s<br />

board. Claude Capron <strong>is</strong> the CEO of Thermocoax.<br />

Adv<strong>is</strong>ers<br />

Acquirer – Mayer Brown, Guillaume Kuperfils, Pascal Druhen-Chanaux, Laure Canu (Legal);<br />

Laurent Borey, Jérémie Thézée, Julie Barbier (Tax); Jean-Philippe Lambert, Patrick Teboul (Debt);<br />

CMI, Lubomir Mortchev (Commercial due diligence); Oder<strong>is</strong>, Guillaume Lauilhé, Julien Passerat<br />

(Financial due diligence); Fidal, Jean-Pascal Amoros, Caroline Ackermann (Legal, financial and social<br />

due diligence).<br />

26 UNQUOTE AUGUST/SEPTEMBER 10 ENTIRE CONTENTS COPYRIGHT 2010 INCISIVE MEDIA INVESTMENTS LTD<br />

www.unquote.com/france


unquote<br />

buyouts<br />

Vendors – UBS, Fabrice Scheer, Arnaud Fauqueur, Erwan Meurzec (Corporate finance); Paul<br />

Hastings, Olivier Deren, Mathias Roth, Mounir Letayf (Legal); Allard de Waal, Laurent Ragot<br />

(Tax); Ernst & Young, Emmanuel Picard (Financial due diligence); ADL, Vincent Bamberger<br />

(Market due diligence).<br />

Debt – Gide Loyrette Nouel, Chucri Serhal (Legal).<br />

ERCP backs Hyper Embal and Valeurd<strong>is</strong> MBO<br />

Transaction<br />

Edmond de Rothschild Capital Partners (ERCP) has taken a 60% stake in Financière HEVD, the<br />

holding company of merged French firms Hyper Embal and Valeurd<strong>is</strong>.<br />

The remaining 40% <strong>is</strong> now owned by the companies’ management teams. The overall value of the MBO<br />

has not been d<strong>is</strong>closed, but ERCP provided close <strong>to</strong> 10m of equity. Th<strong>is</strong> <strong>is</strong> the fifth investment from<br />

ERCP’s ERLF II fund.<br />

MBO<br />

Hyper Embal/Valeurd<strong>is</strong><br />

Founded 1990/1994<br />

Location Seclin/Gravigny<br />

Sec<strong>to</strong>r Containers and<br />

packaging<br />

Turnover 100m<br />

(combined)<br />

The involvement of ERCP <strong>is</strong> hoped <strong>to</strong> accelerate the merger of the two companies and lead <strong>to</strong> a strengthened<br />

position in the French market. The consolidated structure will generate a turnover of around 100m.<br />

Debt<br />

Senior debt was co-led by Société Générale and Crédit du Nord, with the support of Banque<br />

Populaire du Nord and LCL. The prec<strong>is</strong>e amount was not d<strong>is</strong>closed but <strong>is</strong> around 3x the companies’<br />

consolidated EBITDA.<br />

Company<br />

Hyper Embal and Valeurd<strong>is</strong> both special<strong>is</strong>e in packaging for large food retailers. Hyper Embal <strong>is</strong> based<br />

in the north of France and focuses on breadbags and packaging for fresh products, of which it currently<br />

s<strong>to</strong>cks more than 2,600.<br />

Normandy-based Valeurd<strong>is</strong> d<strong>is</strong>tributes shopping bags and d<strong>is</strong>posable cutlery, sourced in Europe and<br />

Asia. Both companies generated a <strong>2009</strong> turnover close <strong>to</strong> 50m.<br />

People<br />

Erick Fouque, Olivier Dubs and Marie Londero led the deal for ERCP. Alain Flitz <strong>is</strong> the CEO of Hyper<br />

Embal. Daniel Guibert <strong>is</strong> the CEO of Valeurd<strong>is</strong>.<br />

Adv<strong>is</strong>ers<br />

Equity – Hoche Société d’Avocats, Jean-Luc Blein, Laurent Bensaid, Marie Peyréga (Legal and<br />

tax); KPMG, Axel Rebaudières, Guillaume Monin (Financial due diligence); Diligence Partners,<br />

Delphine Mathez, Nicolas Moulin-Fournier (Strategic due diligence).<br />

Vendor – Fidac, Frédéric Frésiers (Legal).<br />

NextStage backs Groupe ACR MBO with 8.2m<br />

Transaction<br />

NextStage has provided 8.2m <strong>to</strong> back the partial buyout of spare au<strong>to</strong> parts d<strong>is</strong>tribu<strong>to</strong>r Groupe<br />

ACR. The investment – effectively part buyout and part growth funding – was performed mostly<br />

MBO<br />

Groupe ACR<br />

Location Gennevilliers<br />

Sec<strong>to</strong>r Au<strong>to</strong> parts<br />

Founded 1993<br />

Turnover 40m<br />

Staff 115<br />

ENTIRE CONTENTS COPYRIGHT 2010 INCISIVE MEDIA INVESTMENTS LTD UNQUOTE AUGUST/SEPTEMBER 10 27<br />

www.unquote.com/france


uyouts<br />

unquote<br />

through the FCPR NextStage PME Championnes II fund, in conjunction with four other NextStage<br />

FIP funds.<br />

It allows the private equity firm <strong>to</strong> secure a significant minority stake in the company (30-50%). The<br />

remainder of the shares are now owned by ACR’s management. One of the company’s founders has<br />

exited the business.<br />

NextStage was attracted by the company’s focus on innovation, as well as its record of sustained growth<br />

throughout the past decade (+20% per annum since 2001). The new funds and the presence of a<br />

recogn<strong>is</strong>ed financial backer will help ACR finance its expansion across France and develop its “H+4”<br />

rapid delivery service.<br />

Debt<br />

LCL and Société Générale provided banking facilities, which account for a small amount of the overall<br />

investment.<br />

Company<br />

Founded in 1993, Groupe ACR special<strong>is</strong>es in the d<strong>is</strong>tribution of spare au<strong>to</strong> parts. It compr<strong>is</strong>es two<br />

branches: ACR, which focuses on braking and general chass<strong>is</strong> parts; and Autec, which special<strong>is</strong>es in<br />

starters and alterna<strong>to</strong>rs. Based in Gennevilliers, the group employs 115 people and posted a 40m<br />

turnover for <strong>2009</strong>.<br />

People<br />

Nicolas de Saint Etienne and Aloys de Fontaines led the deal for NextStage. Jean Rousseau <strong>is</strong> co-founder<br />

and chairman of ACR, while Samuel Denos <strong>is</strong> CEO of the company. Vincent Tornamorell and Karine<br />

Bruggeman represented LCL, while Adrien Bagard was in charge of the transaction for Société Générale.<br />

Adv<strong>is</strong>ers<br />

Equity – CMS Bureau Franc<strong>is</strong> Lefebvre, Arnaud Hugot, Virginie Corbet-Picard (Legal); CDA,<br />

Fabrice Capo<strong>to</strong>s<strong>to</strong> (Tax); Mazars, Pierre Tcher<strong>to</strong>ff, Luc Chambon (Financial due diligence).<br />

Company – Cotty Vivant March<strong>is</strong>io & Lauzeral, Philippe Lauzeral, Franço<strong>is</strong> Brocard, Marie Nezam<br />

(Legal); Franck Le Mentec (Tax); Cro<strong>is</strong>sance Partenaires, Pierre Miallot, Julien Jeremie, Charles<br />

Huyghes Despointes (M&A).<br />

exits<br />

TRADE SALE<br />

PriceMin<strong>is</strong>ter<br />

c200m<br />

Location Par<strong>is</strong><br />

Sec<strong>to</strong>r Internet<br />

Founded 2001<br />

Turnover 40m<br />

EBIT 7m<br />

Staff >200<br />

Atlas Venture et al. sell shares in PriceMin<strong>is</strong>ter<br />

Transaction<br />

Japanese e-commerce special<strong>is</strong>t Rakuten has acquired a 100% stake in the PriceMin<strong>is</strong>ter group from<br />

Atlas Venture, Phillimore, Technocap, Quilvest and individual shareholders.<br />

The company was acquired by Rakuten’s European branch and <strong>is</strong> valued at around 200m. Private equity<br />

funds owned slightly more than 20% of the company prior <strong>to</strong> the sale. Atlas was the major private equity<br />

shareholder, closely followed by Quilvest, while Phillimore and Technocap (who had invested in the early<br />

stages) retained smaller stakes. Individual shareholdings and returns remain und<strong>is</strong>closed.<br />

28 UNQUOTE AUGUST/SEPTEMBER 10 ENTIRE CONTENTS COPYRIGHT 2010 INCISIVE MEDIA INVESTMENTS LTD<br />

www.unquote.com/france


unquote<br />

exits<br />

The major fac<strong>to</strong>r in the sale’s timing was <strong>to</strong> allow private equity funds <strong>to</strong> exit. PriceMin<strong>is</strong>ter was<br />

originally on track for a successful IPO in early 2008 but, in the face of market turmoil, the owners<br />

chose <strong>to</strong> postpone and look for another means of exit.<br />

Rakuten, a Japanese e-commerce special<strong>is</strong>t, hopes the acqu<strong>is</strong>ition will help it establ<strong>is</strong>h itself in Europe<br />

after similar acqu<strong>is</strong>itions in China (Badoo) and the US (LinkShare). It was also attracted by France’s<br />

significant e-commerce growth rate of more than 25% per annum, compared <strong>to</strong> 15% for Japan. The new<br />

owner expects the company <strong>to</strong> expand its business in Spain and the UK, create subsidiaries and perform<br />

several acqu<strong>is</strong>itions in the future.<br />

Previous funding<br />

Technocap led a 1.8m first round of funding for the firm in 2001, alongside a syndicate of corporate<br />

and private inves<strong>to</strong>rs. 3i then led a 7m investment in PriceMin<strong>is</strong>ter back in 2005, alongside a syndicate<br />

compr<strong>is</strong>ing Quilvest and private inves<strong>to</strong>rs. After the PriceMin<strong>is</strong>ter acqu<strong>is</strong>ition of Mixad in 2007, Mixad<br />

backer Atlas Venture entered the equity syndicate through a share swap. 3i sold its stake <strong>to</strong> Quilvest, Atlas<br />

Ventures and the founders in November <strong>2009</strong>, making Atlas the largest private equity shareholder.<br />

Company<br />

Founded in 2001, PriceMin<strong>is</strong>ter started as an e-commerce website dedicated <strong>to</strong> linking buyers and sellers<br />

online and assuring the safety of the transaction for both parties. Since then, the group has expanded with<br />

several acqu<strong>is</strong>itions and <strong>to</strong>day compr<strong>is</strong>es www.pricemin<strong>is</strong>ter.com, travel price compar<strong>is</strong>on website www.<br />

voyagermoinscher.com and real-estate platform www.avendrealouer.fr, among other special<strong>is</strong>t websites.<br />

PriceMin<strong>is</strong>ter has more than 12 million reg<strong>is</strong>tered users. The group posted a 40m turnover and 7m<br />

EBIT for <strong>2009</strong> and employs more than 200 people.<br />

People<br />

Fred Destin led the deal for Atlas. Pierre Kosciusko-Morizet <strong>is</strong> the founder and CEO of PriceMin<strong>is</strong>ter;<br />

he will stay at h<strong>is</strong> post for a further five <strong>year</strong>s, along with the rest of the management. Hiroshi Mikitani<br />

<strong>is</strong> the founder and CEO of Rakuten.<br />

Adv<strong>is</strong>ers<br />

Company – Gide Loyrette Nouel, Pierre Karpik (Legal); Arma Partners, Eric Lawson-Smith<br />

(Corporate finance).<br />

Truffle Capital floats Carmat for 15.5m<br />

Transaction<br />

Artificial heart developer Carmat has completed its IPO on the Alternext of NYSE-Euronext Par<strong>is</strong>,<br />

ra<strong>is</strong>ing 15.5m. A <strong>to</strong>tal of 800,000 new shares have been <strong>is</strong>sued, representing 22.15% of the company’s<br />

capital. Shares were priced at 18.75. The IPO values Carmat at more than 75m.<br />

Truffle Capital now retains a 31.8% stake in Carmat. It <strong>is</strong> currently not considering a complete exit<br />

from the company, even after the 180-day lock-up period expires. The capital increase will be used <strong>to</strong><br />

finance the final<strong>is</strong>ation of pre-clinical testing, as well as the first clinical trials of Carmat’s artificial heart<br />

on humans. Carmat aims <strong>to</strong> complete these tests by 2011.<br />

IPO<br />

Carmat SAS<br />

75m<br />

Location<br />

Sec<strong>to</strong>r<br />

Founded 2008<br />

Staff 36<br />

Vélizy-<br />

Villacoublay<br />

Medical<br />

equipment<br />

Previous funding<br />

Truffle Capital co-founded Carmat and led its first round of financing with 5m in 2008. Aerospace<br />

ENTIRE CONTENTS COPYRIGHT 2010 INCISIVE MEDIA INVESTMENTS LTD UNQUOTE AUGUST/SEPTEMBER 10 29<br />

www.unquote.com/france


exits<br />

unquote<br />

company EADS and the Fondation Alain Carpentier provided an additional 2.5m. French national<br />

agency for industrial innovation Oséo awarded the company with 33m in grants and loans.<br />

Company<br />

Carmat was created in 2008 as a spinout of the collaboration between Alain Carpentier and EADS.<br />

Its artificial human heart pro<strong>to</strong>type has been patented and <strong>is</strong> undergoing pre-clinical testing. It <strong>is</strong><br />

functionally similar <strong>to</strong> the human heart in both ana<strong>to</strong>mic and functional terms – notably via au<strong>to</strong>matic<br />

regulation of heart rate and blood flow according <strong>to</strong> the patient’s physiological needs. Meeting the<br />

human body’s biocompatibility criteria, Carmat’s device virtually eliminates the rejection <strong>is</strong>sues<br />

associated with traditional heart transplants.<br />

People<br />

Dr Philippe Pouletty led the IPO for Truffle Capital and sits on Carmat’s board. Marcello Conviti <strong>is</strong><br />

CEO of Carmat.<br />

EXIT<br />

Groupe Keria<br />

6-9m<br />

Location Echirolles<br />

Sec<strong>to</strong>r Durable<br />

household<br />

products<br />

Founded 1982<br />

Turnover 110m (<strong>2009</strong>)<br />

Siparex exits Keria<br />

Transaction<br />

Siparex has sold its entire minority stake in lighting products retailer Keria <strong>to</strong> the founding family.<br />

Previous funding<br />

Siparex invested 3m in 2000 through its SPF II fund and its l<strong>is</strong>ted vehicle Siparex Cro<strong>is</strong>sance, in<br />

exchange for less than 10% of the company’s shares. The private equity firm has announced a return on<br />

its initial investment of slightly more than 2x, which would value the sale at 6-9m.<br />

Keria has experienced sustained growth since Siparex’s initial investment; the company’s turnover has<br />

doubled and it now operates three times more outlets following a bolt-on acqu<strong>is</strong>ition in 2008. It <strong>is</strong> the<br />

first lighting products retailer in France and <strong>is</strong> looking at a possible international expansion.<br />

Company<br />

Founded in 1982, Keria <strong>is</strong> a lighting fixtures retailer based in Echirolles. Following the acqu<strong>is</strong>ition of<br />

Laurie Lumière in 2008, the group now operates 140 s<strong>to</strong>res, mainly located on the outskirts of various<br />

French cities. Keria posted a 110m turnover for <strong>2009</strong>.<br />

People<br />

Benoit Méta<strong>is</strong> led the Siparex team, which also compr<strong>is</strong>ed Thierry Candelier and Emmanuel Botzung.<br />

Marcel Barbe <strong>is</strong> the founder and chairman of the superv<strong>is</strong>ory board of Keria.<br />

EXIT<br />

Trecobat<br />

Location Lannil<strong>is</strong><br />

Sec<strong>to</strong>r Home<br />

construction<br />

Founded 1972<br />

Turnover c100m (<strong>2009</strong>)<br />

Staff 250<br />

Adv<strong>is</strong>ers<br />

Equity and company – Mes Louvat Vincent Cach Giraud Vancleemput Plottin, Ludovic<br />

Giraud (Legal).<br />

AXA Private Equity sells Trecobat stake<br />

Transaction<br />

AXA Private Equity has sold its 46.5% stake in home-building group Trecobat <strong>to</strong> the company’s<br />

management team. The amount of the sale remains confidential, but allowed AXA <strong>to</strong> reap a 3x multiple<br />

30 UNQUOTE AUGUST/SEPTEMBER 10 ENTIRE CONTENTS COPYRIGHT 2010 INCISIVE MEDIA INVESTMENTS LTD<br />

www.unquote.com/france


unquote<br />

exits<br />

on its original investment, equating <strong>to</strong> an IRR of 45% per annum. The management team <strong>is</strong> now the<br />

new majority shareholder.<br />

AXA bought the company in 2007 for a price estimated <strong>to</strong> be in the 50-100m range. The private equity<br />

firm was sat<strong>is</strong>fied with the company’s performance despite the downturn; Trecobat’s gross margin has<br />

improved by seven points and the group has increased its market share from 10% <strong>to</strong> 15%. AXA also helped the<br />

management introduce a new corporate governance scheme and implement stronger financial reporting.<br />

Company<br />

Trecobat <strong>is</strong> a home-building group founded in 1972 by Marcel Treguer. Building more than 1,000 homes<br />

per <strong>year</strong>, the group <strong>is</strong> also present in the high-growth segment of timber housing under the “Ma<strong>is</strong>ons Nature<br />

et Bo<strong>is</strong>” brand, with more than 15% of its revenue earned from th<strong>is</strong> segment. It has recently focused part of<br />

its activity on low consumption housing. Based in Lannil<strong>is</strong>, Trecobat employs 250 people and operates in<br />

Brittany, as well as the Loire-Atlantique and the Toulouse regions. It posted a 100m turnover for <strong>2009</strong>.<br />

People<br />

Baudouin d’Hérouville, Alex<strong>is</strong> Lavaillote and Caroline Pihan represented AXA on the deal. Alban Boyé<br />

<strong>is</strong> the managing direc<strong>to</strong>r of Trecobat.<br />

Adv<strong>is</strong>ers<br />

Equity – De Pardieu Brocas Mafféi, Thibaut Caharel, Jean-Franço<strong>is</strong> Pourdieu (Legal).<br />

Management – SCM Juripro, Marcel Hascoet (Legal); Sofico, Michel Gouriten (Financial due<br />

diligence).<br />

EUROPEAN<br />

BUYOUT<br />

REVIEW 2010<br />

VALIDATED BUYOUT DATA.<br />

COMPREHENSIVE OVERVIEW<br />

OF THE BUYOUT MARKET.<br />

The 21st edition of the European Buyout Review provides you with a detailed<br />

analys<strong>is</strong> of the European buyout market from 2005-<strong>2009</strong>.<br />

V<strong>is</strong>it europeanbuyoutreview.com or call +44 (0)20 7484 9884 now for more<br />

information & <strong>to</strong> order your copy.<br />

unquotebooks.com


funds ra<strong>is</strong>ing<br />

unquote<br />

A Austria<br />

BE Belgium<br />

CH Switzerland<br />

D<br />

DEN<br />

EE<br />

Germany<br />

Denmark<br />

Es<strong>to</strong>nia<br />

EI<br />

ES<br />

F<br />

Ireland<br />

Spain<br />

France<br />

FIN Finland<br />

I Italy<br />

LT Lithuania<br />

Group Fund name Base Target (m) Close Closed on (m)<br />

123Venture 123Expansion II F n/d FA c20<br />

123Venture 123Multivova IV F n/d FA c15<br />

21 Centrale Partners 21 Centrale Partners IV F 500 2nd 300<br />

A Plus Finance A Plus Innovation 6 F n/d 1st 35<br />

Agro Invest Agro Plus F 150 1st 80<br />

Arcano Capital Global Opportunity Fund II ES 250 FA 0<br />

Argos Soditic Argos Expansion F 120 1st 45<br />

Ashmore Ashmore Global Special Situations Fund Five UK c$2,000 FA 0<br />

Aurel NextStage Aurel NextStage FCPR Champion Small Cap II F 120 1st 61<br />

Baigo Capital Baigo Capital D 300 1st 100<br />

BlackFin Capital Partners BlackFin Financial Services Fund F 300 1st 60<br />

Cathay Capital Cathay Capital I F 70 1st 50<br />

CEL Partners China Equity Links F 70 1st 43<br />

CIC LBO Partners CIC LBO Fund II F 250 1st 157<br />

DN Capital Global Venture Capital II UK 100 1st 50<br />

Efigestioni Efilog Private Equity I 50 FA 0<br />

Environmental Technologies Fund Environmental Technologies Fund UK 50 FA 0<br />

Finint & Partners NEIP II LX 120 1st 62<br />

Foundations Capital Foundations Capital F n/d 1st 150<br />

Fountain Healthcare Fountain Healthcare Partners 1 EI n/d 1st 75<br />

Gilde Buyout Partners Gilde Buyout Fund IV NL n/a FC 800<br />

Grand Ouest Gestion Ouest Ventures II F 30-50 1st 21<br />

I2BF Venture Fund II UK $100 FA 0<br />

Irdi-Icso IcsoII F 100 1st 64<br />

Kurma Life Science Partners Kurma Biofund F 75 1st 50<br />

LBO France Altercap F 150 FA 0<br />

LBO France Hexagone III F 180 1st n/d<br />

LFPI LFPI Mezzanine LX 300 FA 0<br />

Matignon Invest<strong>is</strong>sement & Gestion MT II F 100 1st 60<br />

Montefiore Investment Montefiore Investment II F n/d 2nd 250<br />

NBGI Private Equity France NBGI Private Equity France I F n/d 1st 50<br />

NBGI Ventures NBGI Technology Fund II UK 60 1st 30<br />

Oakley Capital Oakley Capital Private Equity Bermuda 550 1st n/d<br />

Occam Capital Occam I F 150 1st 35<br />

Ofi Private Equity Ofi Europa I F 100 1st 30<br />

SGAM AI Private Equity PME France Invest<strong>is</strong>sement II F 60 1st 15<br />

Siparex Siparex proximite III F 40 1st 15<br />

The Carlyle Group Carlyle Global Financial Services Partners US n/d FC 1,100<br />

UFG Private Equity Diadème Innovation III F 50 FA 0<br />

UFG Private Equity / Schroders Diadème Global Selection F 100 FA 0<br />

UI Gestion MI5 F 80-100 1st 50<br />

Unigestion Unigestion Environmental Sustainability CH $250 FA 0<br />

Unigestion Unigestion Secondary Opportunity Fund II CH $150 FA 0<br />

Vermeer Capital Vermeer Capital F 90 1st 75<br />

Vespa Capital Vespa 1 UK/F 100 1st 50<br />

WHEB Ventures Private Equity WHEB Ventures Private Equity 2 LP UK 150 4th 114<br />

32 UNQUOTE AUGUST/SEPTEMBER 10 ENTIRE CONTENTS COPYRIGHT 2010 INCISIVE MEDIA INVESTMENTS LTD<br />

www.unquote.com/france


unquote<br />

LX<br />

NL<br />

NOR<br />

Luxembourg<br />

Netherlands<br />

Norway<br />

P<br />

PL<br />

SWE<br />

Portugal<br />

Poland<br />

Sweden<br />

UK<br />

US<br />

FA<br />

United Kingdom<br />

United States<br />

Fund announced<br />

FC<br />

1st<br />

2nd<br />

Fund closed<br />

First close<br />

Second close<br />

Date Stage Geographic Contact Telephone No.<br />

Feb-07 Expansion EU Olivier Goy +33 1 49 26 98 00<br />

Feb-07 Expansion EU Olivier Goy +33 1 49 26 98 00<br />

Mar-10 Buyout EU Gerard Pluvinet +33 1 56 88 33<br />

Feb-07 Early-stage F Niels Court-Payen +33 1 40 08 03 40<br />

Jul-07 Buyout, expansion F Jean-Lou<strong>is</strong> Ruatti +33 1 40 69 48 15<br />

May-08 Fund-of-funds Europe,Asia,US Ignacio Sarría +34 917 00 38 80<br />

Jul-10 Expansion - SMEs France Constance Jay +33 1 53 67 20 50<br />

Jul-08 Buyout, d<strong>is</strong>tressed debt Western Europe, US Mark Coombs, Jerome Booth +44 20 3077 6000<br />

Feb-09 Expansion EU Gregoire Sentilhes 33 1 53 93 49 40<br />

Nov-07 Buyout – mid-market Europe Marcus Bracklo +49 69 17 39 26 00<br />

Feb-10 Buyout, expansion Europe Laurent Bouyoux +33 1 75 00 02 32<br />

Jul-07 Expansion EU, China Mingpo Cai +33 1 42 25 28 00<br />

Apr-07 Expansion EU, China André Loesekrug-Pietri +33 6 85 31 51 59<br />

Nov-08 Buyout F Bertrand Fesneau +33 1 42 66 70 57<br />

May-08 Early-stage EU, US, CEE Nenad Marovac +44 20 7340 1600<br />

Mar-08 Buyout, expansion EU, Middle East, Asia Fabrizio Vet<strong>to</strong>si +39 02 85 86 99 00<br />

Feb-07 Early-stage, expansion EU Peter Horsburgh +44 207 734 1368<br />

Jul-07 Infrastructure EU Matteo Patrone +39 04 38 36 04 05<br />

May-08 Buyout – upper mid-market F Xavier Marin +33 1 55 35 55 00<br />

Jun-08 Early-stage – life sciences Europe A<strong>is</strong>ling Garvey +35 31 66 33 60 7<br />

Jun-10 Buyout – mid-market Europe Koos Teule +31 30 219 2508<br />

Nov-08 Expansion F Eric Cozanet + 33 0 2 99 35 04 00<br />

Apr-10 Cleantech Global Ilya Golubovich<br />

May-08 Buyout, expansion F Renaud du Lac +33 5 34 41 74 17<br />

Nov-09 Early-stage EU Alain Maiore, Thierry Laugel +33 1 58 19 20 53<br />

Apr-09 D<strong>is</strong>tressed debt F Elizabeth O’Reilly +33 1 40 62 76 06<br />

Feb-10 Buyout – Small-cap F Elizabeth O’Reilly +33 1 40 62 7606<br />

Jun-07 Mezzanine F, Western Europe Aimeric Ouaknine +33 1 58 36 44 90<br />

Oct-06 Early-stage, expansion EU, US Guillaume Connan +33 1 53 53 98 12<br />

Dec-08 Buyout, Expansion F Eric B<strong>is</strong>muth +33 1 58 18 68 68<br />

Jul-09 Buyout, expansion F Laurent Allegot +33 1 58 56 18 95<br />

Nov-07 Early-stage Europe Ar<strong>is</strong> Constantinides +44 207 661 5656<br />

Nov-07 Buyout – mid-market Europe Peter Dubens, David Boyd +44 207 766 6900<br />

Apr-07 Expansion F, D, CH Laurent Cadieu +33 1 44 58 92 10<br />

Jul-06 Fund-of-funds EU Olivier Millet +33 1 40 68 17 56<br />

Dec-08 Expansion, buyout F Amar Douhane +33 1 56 37 74 94<br />

Nov-08 Expansion F Den<strong>is</strong> Rodarie +33 4 72 83 23 23<br />

Mar-10 Financial services Global +1 212 813 4900<br />

Jul-07 Buyout, expansion F, EU Patrick L<strong>is</strong>sague +33 1 43 12 01 04<br />

Jul-07 Buyout EU, US Patrick L<strong>is</strong>sague +33 1 43 12 01 04<br />

Jun-09 Buyout, expansion F Aymeric Balmont +33 1 42 56 66 00<br />

Feb-09 Fund-of-funds US, Europe, Asia Hanspeter Bader +41 22 704 41 11<br />

Feb-09 Fund-of-funds Global Hanspeter Bader +41 22 704 41 11<br />

Apr-08 Turnaround F Jean-Lou<strong>is</strong> Detry +33 1 44 20 02 02<br />

Feb-09 Buyout UK, F Nigel Hammond +44 1892 531 373<br />

Apr-10 Venture, growth, cleantech Europe, Israel Joerg Sperling +44 20 7299 41<br />

ENTIRE CONTENTS COPYRIGHT 2010 INCISIVE MEDIA INVESTMENTS LTD UNQUOTE AUGUST/SEPTEMBER 10 33<br />

www.unquote.com/france


funds-of-funds<br />

unquote<br />

Group Fund name Base Size (m) Closed<br />

Access Capital Partners ACF III Technology F 100 Oct-06<br />

Access Capital Partners Capital Fund IV Growth F 413 May-08<br />

Allianz Private Equity Partners APEP Dachfonds GmbH & Co KG D 750 Mar-06<br />

F&C F&C European Capital Partners LP UK 173 Jul-08<br />

HRJ Capital HRJ Special oppertunities fund I US $195 Apr-08<br />

König & Cie Private Equity Management GmbH König & Cie II International Private Equity D 42 Apr-07<br />

LGT Capital Partner CROWN Premium III LX, D 600 May-07<br />

Lombard Odier Darier Hentsch PE Euro Choice IV CH CHF 776 Jan-09<br />

MPC Münchmeyer Petersen Portfolio Adv<strong>is</strong>ors GmbH Elfte MPC Private Equity GmbH & Co KG D 21.52 Dec-09<br />

Nordcapital Private Equity Nordcapital Private Equity Fonds 8 D 20 Dec-07<br />

Pantheon Ventures Pantheon Europe Fund V UK 1,200 Jun-07<br />

Partners Group Partners Group European Buyout 2005 CH 650 Oct-06<br />

Partners Group Secondary 2008 Partners Group CH 2,500 Dec-09<br />

SGAM AI Private Equity SGAM Private Value Fund F 267 Jul-07<br />

Sw<strong>is</strong>s Re Private Equity Adv<strong>is</strong>ers SRPEP III D 564.3 Mar-06<br />

funds investing<br />

Th<strong>is</strong> table l<strong>is</strong>ts all fully-ra<strong>is</strong>ed funds known <strong>to</strong> be actively seeking investment opportunities in the French market. Information regarding any additional fund<br />

that doesn’t feature on our l<strong>is</strong>t would be well received.<br />

BUYOUT FUNDS<br />

Group Fund name Base Ra<strong>is</strong>ed (m)<br />

21 Centrale Partners 21 Centrale Partners III F/I 330<br />

3i Eurofund V UK 5,000<br />

Abénex Capital AAC France 2005 F 250<br />

Activa Capital Activa Capital II F 320<br />

Advent International Advent International GPE VI UK 6,600<br />

Alchemy Partners Alchemy Investment Plan UK £1,600<br />

Apax Partners SA Apax France VII F 700<br />

Apollo Management Apollo Investment Fund VII US 14,800<br />

Argan Capital Argan Capital Fund UK 425<br />

Argos Soditic Euroknights V F, I,CH 275<br />

ARGUS Capital Ltd ARGUS Capital Partners II UK 262.73<br />

As<strong>to</strong>rg Partners As<strong>to</strong>rg IV F 800.5<br />

AtriA Private Equity AtriA Private Equity III F 300<br />

Aurel NextStage Aurel NextStage FCPR Champion Small Cap I F 100<br />

Avenir Entrepr<strong>is</strong>es Gestion Avenir Entrepr<strong>is</strong>es Développement F 160<br />

Avenir Entrepr<strong>is</strong>es Gestion Avenir Entrepr<strong>is</strong>es Mezzanine F 60<br />

AXA Private Equity AXA Expansion II F 353<br />

AXA Private Equity AXA LBO Fund IV F 1,600<br />

AXA Private Equity AXA Secondary Fund IV F 2,900<br />

Bain Capital Bain Capital IX US $8,000 + $2,000 co-invest<br />

Bain Capital Bain Europe III US 3,500<br />

Balmoral Capital Balmoral I UK n/d<br />

Barclays Private Equity Barclays Private Equity European Fund III UK 2,400<br />

BC Partners BC European Capital VIII UK 5,500<br />

Blacks<strong>to</strong>ne Capital Partners Blacks<strong>to</strong>ne Capital Partners V UK $21,700<br />

Bridgepoint Bridgepoint Development Capital I UK 300<br />

Bridgepoint Bridgepoint European Fund IV UK 5,800<br />

34 UNQUOTE AUGUST/SEPTEMBER 10 ENTIRE CONTENTS COPYRIGHT 2010 INCISIVE MEDIA INVESTMENTS LTD<br />

www.unquote.com/france


unquote<br />

Type Region Contact Telephone No.<br />

Venture UK, F, D Dominique Peninon +33 1 56 43 61 00<br />

Venture Europe Dominique Peninon +33 1 56 43 61 00<br />

Buyout, venture Global Antje Weykopf +49 89 38 00 17790<br />

Buyout Europe Ham<strong>is</strong>h Mair +44 20 768 8000<br />

D<strong>is</strong>tressed assets Global Duran Cur<strong>is</strong> +1 650 327 50 23<br />

Buyout Europe, US Ralph Günther +49 30 20 30 51 00<br />

Buyout Europe, US Maximilian Brönner +41 55 415 96 00<br />

Fund-of-funds Europe Thomas Frei +41 44 214 1342<br />

Buyout Europe Jens Hochbrunn +49 40 380224128<br />

Fund-of-funds Europe, US Meike Reckling +49 40 37 48 3415<br />

Fund-of-funds Europe Helen Steers +44 20 7484 6200<br />

Buyout - small-mid-large cap Europe Dr Cyrill Wipfli +41 41 768 85 85<br />

Secondary fund positions Europe Dr Cyrill Wipfli +41 41 768 85 85<br />

Fund-of-funds Europe,US Richard Dalaud +33 1 56 37 88 87<br />

Buyout Europe, US Harold We<strong>is</strong>s +41 43 285 21 21<br />

Closed Stage Region<br />

Sep-06 Buyout F<br />

Nov-06 Buyout – mid-market Europe, Asia<br />

Dec-05 Buyout F<br />

Mar-07 Buyout F<br />

Mar-08 Buyout Western Europe/US<br />

n/a Buyout UK, Western Europe<br />

Jun-09 Buyout F<br />

Feb-09 Buyout Global<br />

0ct-06 Buyout Nordic, Western Europe, CEE<br />

May-06 Buyout Europe<br />

Jan-07 Buyout Central & Eastern Europe<br />

May-08 Buyout F<br />

Jan-07 Buyout F<br />

Nov-05 Buyout F, Europe<br />

Mar-08 Buyout, expansion F<br />

Feb-08 Buyout – small-/mid-cap F<br />

Sep-07 Buyout – small-/mid-cap F, D, IT<br />

Jun-08 Buyout F, D, IT<br />

Sep-07 Buyout US, Europe<br />

2006 Buyout Global<br />

2008 Buyout Europe<br />

2007 Buyout UK, Europe<br />

Nov-07 Buyout Europe<br />

May-05 Buyout Europe<br />

Aug-07 Buyout Europe, UK, US<br />

Jul-07 Buyout UK, Europe<br />

Oct-08 Buyout Europe<br />

ENTIRE CONTENTS COPYRIGHT 2010 INCISIVE MEDIA INVESTMENTS LTD UNQUOTE AUGUST/SEPTEMBER 10 35<br />

www.unquote.com/france


funds investing<br />

unquote<br />

BUYOUT FUNDS<br />

Group Fund name Base Ra<strong>is</strong>ed (m)<br />

Butler Capital Partners France Private Equity III F 325<br />

Candover Candover 2005 Fund UK 3,500<br />

Carlyle Group Carlyle Europe Partners III US 5,350<br />

CCMP Capital Inves<strong>to</strong>rs CCMP II US $3,400<br />

Charterhouse Charterhouse Capital Partners IX UK 4,000<br />

Cinven The Fourth Cinven fund UK 6,500<br />

Climate Change Capital Ltd Climate Change Capital Private Equity fund UK 200<br />

Cobalt Capital Cobalt Investment F 150<br />

Cognetas Cognetas Fund II UK 1,260<br />

CVC Capital Partners CVC European Equity Partners IV UK 6,000<br />

Doughty Hanson Doughty Hanson & Co Fund V UK 3,000<br />

Edmond de Rothschild Capital Partners ERLF II F 300<br />

Electra Partners LLP Electra Partners Club 2007 fund UK £100<br />

Englefield Capital Englefield Capital II UK 1,060<br />

Fidelity Equity Partners FEP 1 UK/US £350<br />

Finadavance Finadvance Capital III F 82<br />

First Reserve Corporation First Reserve Fund XI US $7,800<br />

GI Partners GI Partners Fund III US $1,900<br />

GMT Communications Partners GMT Communications Partners III UK 350<br />

Goldman Sachs GS Capital Partners VI US $20,300<br />

H.I.G. Europe H.I.G. European Partners UK 600<br />

Hellman & Friedman Hellman & Friedman Capital Partners VII US $8,800<br />

HgCapital HgCapital V LP UK £830<br />

IK Investment Partners IK 2007 UK 1,675<br />

Investcorp Technology Partners Investcorp Technology Partners III LP US/UK $500<br />

iXEN Partners iXEN III F 500<br />

Kohlberg Krav<strong>is</strong> Robert KKR European Fund III US 6,000<br />

L Capital Management L Capital FCPR 2 F 325<br />

LBO France Hexagone II F 152<br />

LBO France White Knights VIII F c1,000<br />

MBO Partenaires FCPR MBO II F 150<br />

Montagu Private Equity Montagu III LP UK £2,260<br />

NBGI Private Equity France NBGI Private Equity French Fund I F 100<br />

PAI partners PAI Europe V F 5,400<br />

Palamon Capital Partners Palamon European Equity II LP UK 670<br />

Pamplona Capital Management Pamplona Capital Parnters II LP UK 1,300<br />

Patron Capital Patron Capital LP III UK 895<br />

Pechel Industries Partenaires Pechel Industries III F 165<br />

Permira Permira IV UK 11,000<br />

Pragma Capital Pragma II F 345<br />

Sagard Sagard II F 1,000<br />

Siparex Group Siparex Middle Market II F 150<br />

Summit Partners Summit Partners Europe Private Equity Fund US 1,000<br />

TA Associates TA XI LP US $4000<br />

TCR Capital Partners TCR Capital Partners III F 161<br />

TDR Capital TDR Capital II UK 1,750<br />

Terra Firma Terra Firma Capital Partners III UK 5,400<br />

The Riverside Company Riverside Europe Fund III BE 315<br />

TowerBrook Capital Partners LP TowerBrook Inves<strong>to</strong>rs II LP UK 1,300<br />

Vespa Capital Vespa Capital UK 80<br />

Vitruvian Partners Vitruvian Partners I UK 925<br />

Warburg Pincus Warburg Pincus Private Equity X LP US $15,000<br />

Weinberg Capital Partners WCP I F 4<br />

36 UNQUOTE AUGUST/SEPTEMBER 10 ENTIRE CONTENTS COPYRIGHT 2010 INCISIVE MEDIA INVESTMENTS LTD<br />

www.unquote.com/france


unquote<br />

Closed Stage Region<br />

Sep-05 Buyout F<br />

Nov-05 Buyout Europe, US<br />

Sep-07 Buyout US, Europe<br />

Jan-08 Buyout, expansion US, Europe, Asia<br />

Arpil-09 Buyout Europe, UK<br />

Jun-06 Buyout Europe, UK<br />

Sep-07 Buyout, expansion – cleantech Europe<br />

Jan-07 Buyout Europe<br />

Jul-05 Buyout Western Europe<br />

Aug-05 Buyout Europe<br />

May-07 Buyout Europe<br />

Feb-08 Buyout F<br />

Jun-08 Buyouts, expansion, mezzanine UK, Europe<br />

Jan-07 Buyout UK, Europe<br />

Apr-07 Buyout UK, Europe<br />

Jun-06 Buyout F<br />

Jul-06 Buyout, expansion – energy US, UK, Europe<br />

Nov-08 Buyout US, UK, Europe<br />

Jul-07 Buyout UK, Europe<br />

Jun-07 Buyout Global<br />

Jul-07 Buyout UK, Europe<br />

Nov-08 Buyout US, UK, Europe<br />

Feb-06 Buyout Europe, UK<br />

Oct-07 Buyout Europe<br />

Jan-08 Buyout – technology US, Europe<br />

Nov-08 Buyout F<br />

May-08 Buyout Europe<br />

Mar-06 Buyout Europe, US<br />

Jul-06 Buyout Europe<br />

Mar-09 Buyout Western Europe<br />

Jun-06 Buyout F<br />

Jun-05 Buyout Europe, UK<br />

Jan-09 Buyout, expansion F<br />

May-08 Buyout Europe<br />

Jun-06 Buyout, expansion Europe<br />

Sep-07 Bu<strong>to</strong>ut, expansion Europe, North America<br />

Mar-07 Buyout, expansion Europe<br />

Oct-08 Buyout, expansion F<br />

Sep-06 Buyout Europe, US, Japan<br />

Apr-08 Buyout F<br />

Dec-06 Buyout F<br />

May-08 Buyout – small-mid-cap F<br />

May-08 Buyout Europe<br />

Sep-09 Buyout, expansion US, Europe, India<br />

May-08 Buyout F<br />

Jun-06 Buyout – mid-market Western Europe<br />

May-07 Buyout UK, Europe<br />

Jul-07 Buyout UK, Europe<br />

Mar-06 Buyout – mid-market US, UK, Europe<br />

Mar-10 Buyout F, UK<br />

Feb-08 Buyout UK, Northern Europe<br />

May-08 Buyout Global<br />

Jan-06 Buyout F, Southern Europe<br />

ENTIRE CONTENTS COPYRIGHT 2010 INCISIVE MEDIA INVESTMENTS LTD UNQUOTE AUGUST/SEPTEMBER 10 37<br />

www.unquote.com/france


funds investing<br />

unquote<br />

EARLY-STAGE/EXPANSION FUNDS<br />

Fund name Group Base Ra<strong>is</strong>ed (m)<br />

360º Capital Partners 360º Capital Partners F/I 100<br />

3i Growth Capital fund UK 1,200<br />

Accel Partners Accel London III UK $525<br />

Access Capital Partners ACF III Technology F 307<br />

Advent Venture Partners Advent Private Equity Fund IV UK £129<br />

Alven Capital Alven Capital III F 100<br />

Amadeus Capital Partners Amadeus III UK £160<br />

Atlas Venture Atlas Venture Fund VIII UK $283<br />

Balder<strong>to</strong>n Capital Benchmark Europe III UK $550<br />

Bellevue Group BB Biotechventures CH 104<br />

Capricorn Venture Partners Capricorn Cleantech Fund BE 100<br />

Credit Agricole Private Equity Capenergie F 109<br />

Demeter Partners 2 Demeter 2 F 203<br />

DFJ Esprit Prelude Trust Plc UK £50<br />

Earlybird Earlybird IV D 127<br />

Edmond de Rothschild Investment Partners Winch Capital 2 F 250<br />

Emerald Technology Ventures SAM Private Equity Sustainability Fund II CH 135<br />

Emertec Gestion Emertec IV F 60<br />

Environmental Technologies Fund Environmental Technologies Fund UK 100<br />

Epi-V Epi-V UK 50<br />

Frontiers Capital Frontiers Capital III UK £25<br />

Hasso Plattner Ventures Hasso Plattner Ventures Europe UK 100<br />

Index Ventures Index Ventures Growth I LP UK 400<br />

Index Ventures Index Ventures V CH 350<br />

Innovacom Innovacom 6 F 150<br />

I-Source Gestion I-Source 3 F 60<br />

Kennet Partners Kennet III UK 200<br />

Lime Rock Partners Lime Rock Fund V US $1,400<br />

Milk Capital Milk Capital F 20<br />

NanoDimension AG NanoDimension LP Cayman Islands 45<br />

NBGI Ventures NBGI Technology Fund II UK 30<br />

NeoMed NeoMed Innovation IV N 104<br />

Newfund Newfund 1 F 72<br />

Partech International Partech Funds V US/F $250<br />

Perusa Partners Perusa Partners I UK 155<br />

Platina Finance Ltd European Renewable Energy Fund 1 LP UK £75<br />

Serena Capital Serena Capital F 100<br />

Sofinnova Parnters Sofinnova Capital VI F 260<br />

SV Life Sciences SV Life Sciences Fund IV US $572<br />

Ventech Ventech Capital III F 150<br />

Welling<strong>to</strong>n Partners Welling<strong>to</strong>n Partners Ventures IV Technology UK 265<br />

XAnge Xpansion F 50<br />

OTHER FUNDS<br />

Fund name Group Base Ra<strong>is</strong>ed (m)<br />

Ac<strong>to</strong> Mezzanine Ac<strong>to</strong> Mezzanine F 187<br />

Babson Capital Europe Almack Mezzanine I UK 800<br />

CIC Mezzanine CIC Mezzanine II F 107<br />

ARCIS Group ESD Fund IV UK 354<br />

Intermediate Capital Group Plc European Mezzanine Fund IV UK £1,250<br />

IFE Conseil IFE Conseil II LX 300<br />

Indigo Capital Indigo Capital V UK 550<br />

Kreos Capital Kreos III UK 200<br />

Park Square Capital Park Square Capital Partners LP UK 1,050<br />

Partners Group Partners Group Global Mezzanine 2007 CH 447<br />

Summit Partners Summit Partners Subordinated Debt Fund IV US $825<br />

38 UNQUOTE AUGUST/SEPTEMBER 10 ENTIRE CONTENTS COPYRIGHT 2010 INCISIVE MEDIA INVESTMENTS LTD<br />

www.unquote.com/france


unquote<br />

Closed Stage Region<br />

Apr-08 Early-stage F, I<br />

Mar-10 Expansion UK, Europe<br />

Dec-08 Early-stage, expansion Europe, Israel<br />

Oct-06 Early-stage UK, Europe<br />

Dec-05 Early-stage Europe, US<br />

Mar-08 Early-stage, expansion F<br />

Mar-07 Early-stage UK, Europe<br />

Feb-09 Early-stage Europe, US<br />

Nov-06 Early-stage UK, Europe<br />

Jan-06 Early-stage Europe, US<br />

Jun-08 Early-stage Europe<br />

Sep-07 Early-stage, buyout F, UK, I, D<br />

Dec-09 Early-stage, expansion F,D, ES<br />

Apr-00 Early-stage UK, Europe<br />

Sep-08 Early-stage, expansion Western Europe<br />

Nov-09 Expansion F<br />

Apr-07 Early-stage – cleantech US, UK, Western Europe<br />

Jan-09 Early-stage F<br />

Oct-07 Early-stage – cleantech UK, Europe<br />

Aug-07 Early-stage – energy UK, Europe, US<br />

Jun-06 Early-stage UK, Europe<br />

Jul-08 Early-stage Europe, Isreal<br />

Jan-08 Expansion Europe<br />

Mar-09 Early-stage UK, Europe, Israel<br />

Nov-07 Early-stage, expansion F, Europe, US<br />

Mar-08 Early-stage, expansion Western Europe<br />

Jul-08 Expansion, technology US, Europe<br />

Jun-08 Expansion – energy US, UK, Europe<br />

Jul-08 Early-stage, expansion Global<br />

Mar-07 Early-stage – nanotechnology Europe, North America<br />

Aug-07 Early-stage – medical technology Europe/US<br />

Jan-06 Early-stage N, SWE, F, CH<br />

Jul-09 Early-stage, Expansion F<br />

Jun-08 Early-stage, expansion US, Europe<br />

Apr-08 Early-stage DACH, Europe<br />

Jan-08 Early-stage, expansion – renewable energy Europe<br />

Jul-09 Early-stage, expansion F, Western Europe<br />

Feb-10 Early-stage, expansion Europe<br />

Feb-07 Early-stage – life sciences US, UK, Europe<br />

Nov-07 Early-stage Europe<br />

Jan-08 Early-stage, expansion Europe<br />

Apr-08 Expansion F<br />

Closed Stage Region<br />

Mar-08 Mezzanine F<br />

Jun-06 Mezzanine UK, Europe<br />

May-09 Mezzanine France<br />

Oct-08 Secondaries Europe<br />

Apr-07 Mezzanine UK, Europe<br />

Nov-06 Mezzanine BE, NL, LX, D, F, ES, I<br />

Jul-07 Mezzanine Europe<br />

Apr-07 Venture debt UK, Europe, Israel<br />

Jan-05 Mezzanine UK, Europe<br />

May-08 Mezzanine Europe<br />

May-08 Mezzanine US, EU<br />

ENTIRE CONTENTS COPYRIGHT 2010 INCISIVE MEDIA INVESTMENTS LTD UNQUOTE AUGUST/SEPTEMBER 10 39<br />

www.unquote.com/france


IPO tracker<br />

unquote<br />

The table below tracks the performance of previously private equity-backed French companies as l<strong>is</strong>ted s<strong>to</strong>ck<br />

Company ICB Subsec<strong>to</strong>r Name Original deal Equity Syndicate<br />

Buyouts<br />

Bureau Veritas Business Support Services n/d, 1995 Wendel Invest<strong>is</strong>sement<br />

Fountaine Pajot Commercial Vehicles & Trucks n/d, 2002 21 Centrale Partners<br />

Homair Hotels n/d, 2005 Montefiore Investment, Avenir Tour<strong>is</strong>me, Uni<br />

Expansion Ouest, Grand Sud Ouest Capital<br />

Legrand Electrical Components & Equipment 3.7bn, 2002 Wendel Invest<strong>is</strong>sement, KKR<br />

Médica Healthcare Equipment & Services 750m, 2006 BC Partners, AXA Private Equity<br />

Outremer Telecom Mobile Telecommunications 70m, 2004 Apax Partners<br />

Rexel Electrical Components & Equipment 3.8bn , 2005 Clay<strong>to</strong>n Dublier & Rice, Eurazeo, Merrill Lunch<br />

Global Private Equity<br />

Seloger.com Real Estate Holding & Development 50m, 2000 AXA Private Equity, Galileo Partners, Alpha<br />

Associes, Alven, Europ@web<br />

Arkoon Software 3.6m, 2003 Sigefi Private Equity, ACE Management, CDC<br />

Entrepr<strong>is</strong>es, Siparex, Initiative & Finance<br />

Au<strong>to</strong> Escape Specialized Consumer Services n/d, 2005 Ofi Private Equity, Viver<strong>is</strong> Management<br />

Carmat Health Care Equipment & Services 7.25m, 2008 Truffle Venture<br />

Celect<strong>is</strong> Biotechnology 13.6m, 2002 BioMedical Venture, AGF Private Equity, Edmond<br />

de Rothschild Investment Parnters, KamInvest,<br />

Odysee Venture<br />

Eurogerm Food Products 5.8m, 2004 Siparex, Carvest<br />

Europacorp Broadcasting & Entertainment n/d GCE JIC<br />

Venture<br />

Innate Pharma Biotechnology 5m, 1999 Sofinnova Partners, GIMV, Auriga Partners, Alta<br />

Partners, AXA Private Equity, Gilde Pechel, Innover<strong>is</strong><br />

LeGuide.com Media Agencies n/d, 2000 Sigefi Ventures Gestion<br />

Metabolic Explorer Speciality Chemicals Ffr 10m, 2000 Spef Ventures, Sofimac, Credit Lyonna<strong>is</strong> Private<br />

Equity, Viver<strong>is</strong> Management, Credit Agricole<br />

Private Equity, SGAM AI<br />

Parrot Telecommunications Equipment 0.55m, 2005 Sofinnova Partners, EPF Partners, Spef Ventures,<br />

SGAM, CIC<br />

Vergnet Industrial Machinery 75k, 1993 Centre Capital Developpement, Demeter Partners,<br />

IPO, CM-COC Capital Prive, Centre Loire Expansion,<br />

Sofimac Partners<br />

Ve<strong>to</strong>quinol Biotechnology 40m, 2003 Banexi Capital Partenaires, 3i<br />

Vival<strong>is</strong> Biotechnology 3m, 2003 FCJE, Creagro, Pays de la Loire Developpement,<br />

Sodero, Dahlia<br />

* country specific sec<strong>to</strong>r index.<br />

Source: Bloomberg<br />

40 UNQUOTE AUGUST/SEPTEMBER 10 ENTIRE CONTENTS COPYRIGHT 2010 INCISIVE MEDIA INVESTMENTS LTD<br />

www.unquote.com/france


unquote<br />

IPO date<br />

Prime<br />

Exchange<br />

Issue price<br />

Market cap<br />

at IPO<br />

P/E Ratio<br />

Industry<br />

benchmark P/E<br />

ratio*<br />

Share price<br />

14/07/2010<br />

Price change<br />

since IPO<br />

Oct-07 Euronext Par<strong>is</strong> 37.75 4.38bn 19.27 n/a 48.60 29% <br />

Jun-07 Euronext Par<strong>is</strong> 30 46m n/a 19.29 10.35 -66% <br />

Jun-07 Euronext Par<strong>is</strong> 5.1 65m 19.66 n/a 2.96 -42% <br />

Apr-06 Euronext Par<strong>is</strong> 19.75 5.35bn 21.62 13.11 25.15 27% <br />

Feb-10 Euronext Par<strong>is</strong> 13 623m n/a 15.1 14.27 10% <br />

Apr-07 Euronext Par<strong>is</strong> 17 360m n/a 16.36 4.30 -75% <br />

Apr-07 Euronext Par<strong>is</strong> 16.5 4.22bn 29.04 13.11 12.19 -26% —<br />

Jan-07 Euronext Par<strong>is</strong> 22.5 375m 27.14 n/a 30.10 34% —<br />

3-month<br />

trend<br />

Jul-07 Euronext Par<strong>is</strong> 4.61 21m n/a n/a 1.37 -70% —<br />

Mar-07 Euronext Par<strong>is</strong> 5.53 29m n/a n/a 2.40 -57% <br />

Jun-10 Euronext Par<strong>is</strong> 18.75 75m n/a n/a 22.15 18% —<br />

Feb-07 Euronext Par<strong>is</strong> 10.25 94m n/a 13.98 8.40 -18% <br />

Apr-07 Euronext Par<strong>is</strong> 16.73 72m 16.4 n/a 9.93 -41% <br />

Jun-07 Euronext Par<strong>is</strong> 15.5 315m 11.26 n/a 5.01 -68% <br />

Dec-06 Euronext Par<strong>is</strong> 4.5 112m n/a 13.98 1.80 -60% <br />

Aug-06 Euronext Par<strong>is</strong> 9.2 31m 22.33 n/a 23.00 150% <br />

May-07 Euronext Par<strong>is</strong> 8.4 170m n/a n/a 5.43 -35% <br />

Jul-06 Euronext Par<strong>is</strong> 23.5 306m 18.32 16.36 12.25 -48% <br />

Aug-07 Euronext Par<strong>is</strong> 13.85 86m n/a 19.29 4.44 -68% <br />

Jan-07 Euronext Par<strong>is</strong> 21 237m 15.1 n/a 24.47 17% —<br />

Jun-07 Euronext Par<strong>is</strong> 10.51 151m n/a n/a 6.94 -34% <br />

ENTIRE CONTENTS COPYRIGHT 2010 INCISIVE MEDIA INVESTMENTS LTD UNQUOTE AUGUST/SEPTEMBER 10 41<br />

www.unquote.com/france


diary dates<br />

unquote<br />

15-17 September 2010<br />

Capital Creation 2010<br />

Le Meridien Beach Plaza, Monte Carlo<br />

www.capitalcreationeurope.com<br />

12-13 Oc<strong>to</strong>ber 2010<br />

EVCA Buyout Forum<br />

Copenhagen, Denmark<br />

www.evca.eu/buyoutforum2010/home.html<br />

13 Oc<strong>to</strong>ber 2010<br />

The AFME/EHYA 5th Annual EHYA Leveraged Finance Conference<br />

The Lancaster London Hotel<br />

Lancaster Terrace<br />

London, W2<br />

Tel: +44 20 7262 6737<br />

www.lancasterlondon.com<br />

14 Oc<strong>to</strong>ber 2010<br />

unquote” Deutsche Private Equity Congress<br />

Munich, Germany<br />

Tel: +44 20 7484 9884<br />

Email: nicola.tillin@inc<strong>is</strong>ivemedia.com<br />

www.deutschepecongress.com<br />

14-15 Oc<strong>to</strong>ber 2010<br />

EVCA Venture Capital Forum<br />

Copenhagen, Denmark<br />

www.evca.eu/venturecapitalforum2010/home.html<br />

4 November 2010<br />

The unquote” Brit<strong>is</strong>h Private Equity Awards 2010<br />

The Northumberland<br />

London, UK<br />

Tel: +44 20 7004 7453<br />

Email: helen.longhurst@inc<strong>is</strong>ivemedia.com<br />

www.brit<strong>is</strong>hprivateequityawards.com<br />

11 November 2010<br />

unquote” Italia Private Equity Congress<br />

Milan, Italy<br />

Tel: +44 20 7484 9884<br />

Email: nicola.tillin@inc<strong>is</strong>ivemedia.com<br />

www.italiapecongress.com<br />

16-19 November 2010<br />

SuperInves<strong>to</strong>r 2010<br />

Westin Hotel<br />

Par<strong>is</strong>, France<br />

www.icbi-events.com/superinves<strong>to</strong>r<br />

10 December 2010<br />

The PE Inves<strong>to</strong>r Relations Conference<br />

London, UK<br />

www.bieevents.com/peir-details<br />

42 UNQUOTE AUGUST/SEPTEMBER 10 ENTIRE CONTENTS COPYRIGHT 2010 INCISIVE MEDIA INVESTMENTS LTD<br />

www.unquote.com/france


Subscription Packages and Reports<br />

The following subscription packages and reports are available from unquote”.<br />

Regional subscription packages<br />

Choose one or more of the following regions:<br />

And choose your subscription package:<br />

Standard Standard Plus Corporate Enterpr<strong>is</strong>e<br />

Deals, Funds and Exits <br />

Monthly Regional Round Up (pdf) <br />

Monthly European Overview (in print) <br />

Special<strong>is</strong>t Intelligence Reports <br />

Email News Bulletins <br />

Archives <br />

Regions 1 1 2 or more All<br />

Multiple Sites 2 Unlimited<br />

Multiple Users 10 Unlimited<br />

Annual Reports Buyout Review Buyout Review All<br />

Who’s Who in Private Equity Online <br />

From £1,200 From £1,500 From £2,000 POA<br />

Annual Reports & Who’s Who<br />

most<br />

popular<br />

Our two annual reports and our online direc<strong>to</strong>ry Who’s Who in Private Equity are also available <strong>to</strong> buy separately:<br />

Who’s Who in Private Equity<br />

www.whoswhoinprivateequity.com<br />

Th<strong>is</strong> online direc<strong>to</strong>ry contains<br />

profiles of more than 4,000 key<br />

contacts from approximately<br />

1,500 companies in 15 European<br />

countries, including legal and<br />

corporate finance adv<strong>is</strong>ers.<br />

From £695<br />

European Buyout Review<br />

www.europeanbuyoutreview.com<br />

Th<strong>is</strong> annual reference guide<br />

contains buyout stat<strong>is</strong>tics and<br />

analys<strong>is</strong> of the market in each major<br />

European country. Includes l<strong>is</strong>ts of<br />

equity and mezzanine providers and<br />

major deals completed.<br />

£1,195<br />

European Fundra<strong>is</strong>ing Review<br />

www.unquote.com/research<br />

The annual source for fundra<strong>is</strong>ing in<br />

Europe. Analyses trends in capital<br />

ra<strong>is</strong>ed and sought, fund sizes and<br />

fundra<strong>is</strong>ing cycles.<br />

£995<br />

unquote.com<br />

For more information or <strong>to</strong> order any of the products l<strong>is</strong>ted, please contact<br />

Nicola Tillin on +44 (0)20 7484 9884 or nicola.tillin@inc<strong>is</strong>ivemedia.com


Private Equity Market Intelligence<br />

As easy as<br />

1,2,3<br />

Deals Intelligence<br />

Global Portfolio Company Performance Data<br />

Fundra<strong>is</strong>ing & LP Information<br />

PRIVATE EQUITY INSIGHT EXCLUSIVE FREE TRIAL OFFER<br />

GLOBAL PORTFOLIO COMPANY PERFORMANCE DATA FREE TRIAL OFFER<br />

Private Equity Insight’s unique Performance Analyser provides the only way <strong>to</strong>: Compare forecast performance models with aggregated actual data;<br />

track performance of portfolio investments; identify performance excellence; track and analyse trends; and ultimately ensure<br />

optimum returns. So, you can either keep making dec<strong>is</strong>ions in the dark, or you can begin <strong>to</strong> base every dec<strong>is</strong>ion on fact.<br />

For more information or <strong>to</strong> arrange your no obligation FREE TRIAL v<strong>is</strong>it www.privateequityinsight.com or email nicola.tillin@inc<strong>is</strong>ivemedia.com<br />

Private Equity Insight - It’s as easy as 1, 2, 3.<br />

unquote

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!